II

108TH CONGRESS 

1ST SESSION S. 1860

To reauthorize the Office of National Drug Control Policy. 

IN THE SENATE OF THE UNITED STATES 

NOVEMBER 14 (legislative day, NOVEMBER 12), 2003

Mr. HATCH (for himself, Mr. BIDEN, and Mr. GRASSLEY) introduced the following bill; which was read twice and referred to the Committee on the 

Judiciary 

A BILL

To reauthorize the Office of National Drug Control Policy.

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SHORT TITLE, REFERENCE, AND TABLE OF 

4 CONTENTS. 

5 (a) SHORT TITLE.—This Act may be cited as the 

6 ‘‘Office of National Drug Control Policy Reauthorization 

7 Act of 2003’’. 

8 (b) AMENDMENT OF OFFICE OF NATIONAL DRUG

9 CONTROL POLICY REAUTHORIZATION ACT OF 1998.—Ex10 cept as otherwise expressly provided, whenever in this Act 

11 an amendment or repeal is expressed in terms of an 
2

•S 1860 IS 

1 amendment to, or repeal of, a section or other provision, 

2 the reference shall be considered to be made to a section 

3 or other provision of the Office of National Drug Control 

4 Policy Reauthorization Act of 1998 (Public Law 105–277; 

5 21 U.S.C. 1701 et seq.). 

6 (c) TABLE OF CONTENTS.—The table of contents for 

7 this Act is as follows:

Sec. 1. Short title, reference, and table of contents. 

TITLE I—ORGANIZATION OF OFFICE OF NATIONAL DRUG 

CONTROL POLICY AND ROLES AND RESPONSIBILITIES 

Sec. 101. Amendments to definitions. 

Sec. 102. Establishment of the Office of National Drug Control Policy. 

Sec. 103. Appointment and responsibilities of the Director. 

Sec. 104. Amendments to ensure coordination with other agencies. 

TITLE II—THE NATIONAL DRUG CONTROL STRATEGY 

Sec. 201. Annual preparation and submission of national drug control strategy. 

Sec. 202. Performance measurements. 

TITLE III—HIGH INTENSITY DRUG TRAFFICKING AREAS PROGRAM AND COUNTER-DRUG TECHNOLOGY ASSESSMENT CENTER 

Sec. 301. Purpose of high intensity drug trafficking areas program. 

Sec. 302. Designation of HIDTAs and evaluation of HIDTA performance. 

Sec. 303. Organization of HIDTAs. 

Sec. 304. HIDTA funding. 

Sec. 305. Assessment of task forces in HIDTA areas. 

Sec. 306. Funding for certain HIDTA areas. 

Sec. 307. Report on intelligence sharing. 

Sec. 308. Counter-Drug Technology Assessment Center. 

TITLE IV—REAUTHORIZATION AND IMPROVEMENT OF THE 

NATIONAL ANTI-DRUG MEDIA CAMPAIGN 

Sec. 401. Short title. 

Sec. 402. Purposes of the national anti-drug media campaign. 

Sec. 403. Roles and responsibilities of the Director, the Partnership for a 

Drug-Free America, and a media buying contractor. 

Sec. 404. Responsible use of Federal funds for the national anti-drug media 

campaign. 

Sec. 405. GAO audit of national media campaign. 

Sec. 406. Authorization for national media campaign. 

TITLE V—AUTHORIZATIONS AND EXTENSION OF TERMINATION 

DATE 
3

•S 1860 IS 

Sec. 501. Authorization of appropriations. 

Sec. 502. Extension of termination date. 

TITLE VI—DESIGNATION OF UNITED STATES ANTI-DOPING 

AGENCY 

Sec. 601. Designation of United States Anti-Doping Agency. 

Sec. 602. Authorization of appropriations. 

TITLE VII—DRUG EDUCATION, PREVENTION, AND TREATMENT 

Sec. 701. Expansion of substance abuse education and prevention efforts. 

Sec. 702. Funding for rural States and economically depressed communities. 

Sec. 703. Residential treatment programs for juveniles. 

Sec. 704. Drug treatment alternative to prison programs administered by State 

or local prosecutors. 

Sec. 705. Funding for residential treatment centers for women and children. 

TITLE VIII—ANABOLIC STEROID CONTROL ACT OF 2003

Sec. 801. Short title. 

Sec. 802. Amendments to the Controlled Substances Act. 

Sec. 803. Sentencing Commission guidelines. 

Sec. 804. Prevention and education programs. 

Sec. 805. National survey on drug use and health. 

TITLE IX—NATIONAL GUARD COUNTER-DRUG SCHOOLS 

Sec. 901. National Guard counter-drug schools. 

TITLE X—MISCELLANEOUS PROVISIONS 

Sec. 1001. Repeals. 

Sec. 1002. Amendment to the Higher Education Act of 1965. 

Sec. 1003. Controlled Substances Act amendment. 

Sec. 1004. Exportation of narcotic and nonnarcotic drugs. 

Sec. 1005. Study of work place environment at ONDCP. 

Sec. 1006. Requirement for Latin American heroin strategy.

1 TITLE I—ORGANIZATION OF OF2 FICE OF NATIONAL DRUG 

3 CONTROL POLICY AND ROLES 

4 AND RESPONSIBILITIES 

5 SEC. 101. AMENDMENTS TO DEFINITIONS. 

6 (a) DEMAND REDUCTION.—Section 702(1) is amend7 ed—

8 (1) in subparagraph (F), by striking ‘‘and’’ 

9 after the semicolon; and 
4

•S 1860 IS 

1 (2) in subparagraph (G), by striking the period 

2 and inserting ‘‘; and’’; and 

3 (3) by adding at the end the following: 

4 ‘‘(H) international drug abuse education, 

5 prevention, treatment, research, rehabilitation 

6 activities, and interventions for drug abuse and 

7 dependence.’’. 

8 (b) OFFICE.—Section 702(9) is amended by striking 

9 ‘‘implicates’’ and inserting ‘‘indicates’’. 

10 (c) STATE AND LOCAL AFFAIRS.—Paragraph (10) of 

11 section 702 is amended to read as follows: 

12 ‘‘(10) STATE AND LOCAL AFFAIRS.—The term 

13 ‘State and local affairs’ means domestic activities 

14 conducted by a National Drug Control Program 

15 agency that are intended to reduce the availability 

16 and use of drugs, including—

17 ‘‘(A) coordination and enhancement of 

18 Federal, State, and local law enforcement drug 

19 control efforts; 

20 ‘‘(B) coordination and enhancement of ef21 forts among National Drug Control Program 

22 agencies and State and local demand reduction 

23 and supply reduction agencies; 

24 ‘‘(C) coordination and enhancement of 

25 Federal, State, and local law enforcement initia-
5

•S 1860 IS 

1 tives to gather, analyze, and disseminate infor2 mation and intelligence among law enforcement 

3 agencies; and 

4 ‘‘(D) other coordinated and joint initiatives 

5 among Federal, State, and local agencies to 

6 promote comprehensive drug control strategies 

7 designed to reduce the demand for, and the 

8 availability of, illegal drugs.’’. 

9 (d) SUPPLY REDUCTION.—Section 702(11) is 

10 amended to read as follows: 

11 ‘‘(11) SUPPLY REDUCTION.—The term ‘supply 

12 reduction’ means any activity of a program con13 ducted by a National Drug Control Program agency 

14 that is intended to reduce the availability or use of 

15 drugs in the United States or abroad, including—

16 ‘‘(A) activities to control international traf17 ficking in, and availability of, illegal drugs, in18 cluding—

19 ‘‘(i) accurate assessment and moni20 toring of international drug production and 

21 interdiction programs and policies; and 

22 ‘‘(ii) coordination and promotion of 

23 compliance with international treaties re24 lating to the production, transportation, or 

25 interdiction of illegal drugs;
6

•S 1860 IS 

1 ‘‘(B) activities to conduct and promote 

2 international law enforcement programs and 

3 policies to reduce the supply of drugs; and 

4 ‘‘(C) activities to facilitate and enhance the 

5 sharing of domestic and foreign intelligence in6 formation among National Drug Control Pro7 gram agencies, relating to the production and 

8 trafficking of drugs in the United States and in 

9 foreign countries.’’. 

10 (e) DEFINITION OF APPROPRIATE CONGRESSIONAL

11 COMMITTEES.—Section 702 is amended by adding at the 

12 end the following: 

13 ‘‘(12) APPROPRIATE CONGRESSIONAL COMMIT14 TEES.—Except where otherwise provided, the term 

15 ‘appropriate congressional committees’ means the 

16 Committee on the Judiciary, the Committee on Ap17 propriations, and the Caucus on International Nar18 cotics Control of the Senate and the Committee on 

19 Government Reform, the Committee on the Judici20 ary, and the Committee on Appropriations of the 

21 House of Representatives.’’. 

22 SEC. 102. ESTABLISHMENT OF THE OFFICE OF NATIONAL 

23 DRUG CONTROL POLICY. 

24 (a) RESPONSIBILITIES.—Section 703(a) is amended 

25 to read as follows: 
7

•S 1860 IS 

1 ‘‘(a) ESTABLISHMENT OF OFFICE.—There is estab2 lished in the Executive Office of the President an Office 

3 of National Drug Control Policy, which shall—

4 ‘‘(1) develop national drug control policy; 

5 ‘‘(2) coordinate and oversee the implementation 

6 of the national drug control policy; 

7 ‘‘(3) assess and certify the adequacy of national 

8 drug control programs and the budget for those pro9 grams; 

10 ‘‘(4) evaluate the effectiveness of National Drug 

11 Control Program agencies’ programs; and 

12 ‘‘(5) develop specific goals and performance 

13 measurements needed to assess the effectiveness 

14 of—

15 ‘‘(A) the national drug control policy; and 

16 ‘‘(B) the programs of the National Drug 

17 Control Program agencies.’’. 

18 (b) POSITIONS.—Section 703(b) is amended to read 

19 as follows: 

20 ‘‘(b) DIRECTOR OF NATIONAL DRUG CONTROL POL21 ICY AND DEPUTY DIRECTORS.—

22 ‘‘(1) DIRECTOR.—There shall be a Director of 

23 National Drug Control Policy who shall head the Of24 fice (referred to in this Act as the ‘Director’). 
8

•S 1860 IS 

1 ‘‘(2) DEPUTY DIRECTOR.—There shall be a 

2 Deputy Director of National Drug Control Policy 

3 who shall report directly to the Director (referred to 

4 in this Act as the ‘Deputy Director’). 

5 ‘‘(3) OTHER DEPUTY DIRECTORS.—

6 ‘‘(A) IN GENERAL.—There shall be a Dep7 uty Director for Demand Reduction, a Deputy 

8 Director for Supply Reduction, and a Deputy 

9 Director for State and Local Affairs. 

10 ‘‘(B) REPORTING.—The Deputy Director 

11 for Demand Reduction, the Deputy Director for 

12 Supply Reduction, the Deputy Director for 

13 State and Local Affairs, and the Chief Scientist 

14 shall report directly to the Deputy Director of 

15 the Office of National Drug Control Policy. 

16 ‘‘(C) DEPUTY DIRECTOR FOR DEMAND RE17 DUCTION.—The Deputy Director for Demand 

18 Reduction shall be responsible for the activi19 ties—

20 ‘‘(i) in subparagraphs (A) through 

21 (H) of section 702(l); and 

22 ‘‘(ii) in section 709, the National 

23 Youth Anti-Drug Media Campaign Act. 

24 ‘‘(D) DEPUTY DIRECTOR FOR SUPPLY RE25 DUCTION.—The Deputy Director for Supply 
9

•S 1860 IS 

1 Reduction shall be responsible for the activities 

2 in subparagraphs (A) through (C) in section 

3 702(11). 

4 ‘‘(E) DEPUTY DIRECTOR FOR STATE AND

5 LOCAL AFFAIRS.—The Deputy Director for 

6 State and Local Affairs shall be responsible for 

7 the activities—

8 ‘‘(i) in subparagraphs (A) through 

9 (D) of section 702(10); and 

10 ‘‘(ii) in section 707, the High Inten11 sity Drug Trafficking Areas Program.’’. 

12 SEC. 103. APPOINTMENT AND RESPONSIBILITIES OF THE 

13 DIRECTOR. 

14 (a) SUCCESSION.—Section 704(a) is amended by 

15 amending paragraph (3) to read as follows: 

16 ‘‘(3) ACTING DIRECTOR.—If the Director dies, 

17 resigns, or is otherwise unable to perform the func18 tions and duties of the office, the Deputy Director 

19 shall perform the functions and duties of the Direc20 tor temporarily in an acting capacity pursuant to 

21 subchapter III of chapter 33 of title 5, United 

22 States Code.’’. 

23 (b) RESPONSIBILITIES.—Section 704(b) is amend24 ed—
10

•S 1860 IS 

1 (1) in paragraph (4), by striking ‘‘Federal de2 partments and agencies engaged in drug enforce3 ment’’ and inserting ‘‘National Drug Control Pro4 gram agencies’’; 

5 (2) in paragraph (7), by inserting after ‘‘Presi6 dent’’ the following: ‘‘and the appropriate congres7 sional committees’’; 

8 (3) in paragraph (13), by striking ‘‘(beginning 

9 in 1999)’’; 

10 (4) by striking paragraph (14) and inserting 

11 the following: 

12 ‘‘(14) shall submit to the appropriate congres13 sional committees on an annual basis, not later than 

14 60 days after the date of the last day of the applica15 ble period, a summary of—

16 ‘‘(A) each of the evaluations received by 

17 the Director under paragraph (13); and 

18 ‘‘(B) the progress of each National Drug 

19 Control Program agency toward the drug con20 trol program goals of the agency using the per21 formance measures for the agency developed 

22 under section 706(d);’’; 

23 (5) in paragraph (15), by striking subpara24 graph (C) and inserting the following:
11

•S 1860 IS 

1 ‘‘(C) supporting the substance abuse infor2 mation clearinghouse administered by the Ad3 ministrator of the Substance Abuse and Mental 

4 Health Services Administration and established 

5 in section 501(d)(16) of the Public Health 

6 Service Act by—

7 ‘‘(i) encouraging all National Drug 

8 Control Program agencies to provide all 

9 appropriate and relevant information; and 

10 ‘‘(ii) supporting the dissemination of 

11 information to all interested entities;’’; and 

12 (6) by inserting at the end the following: 

13 ‘‘(16) shall coordinate with the private sector to 

14 promote private research and development of medi15 cations to treat addiction; 

16 ‘‘(17) shall seek the support and commitment of 

17 State and local officials in the formulation and im18 plementation of the National Drug Control Strategy; 

19 ‘‘(18) shall monitor and evaluate the allocation 

20 of resources among Federal law enforcement agen21 cies in response to significant local and regional 

22 drug trafficking and production threats; and 

23 ‘‘(19) shall submit an annual report to Con24 gress detailing how the Office of National Drug 

25 Control Policy has consulted with and assisted State 
12

•S 1860 IS 

1 and local governments with respect to the formula2 tion and implementation of the National Drug Con3 trol Strategy and other relevant issues.’’. 

4 (c) REVIEW AND CERTIFICATION OF NATIONAL

5 DRUG CONTROL PROGRAM BUDGET.—Section 704(c)(3) 

6 is amended—

7 (1) in subparagraph (C)(iii), by inserting ‘‘and 

8 the appropriate congressional committees,’’ after 

9 ‘‘House of Representatives’’; and 

10 (2) in subparagraph (D)(ii)(II)(bb), by insert11 ing ‘‘and the appropriate congressional committees,’’ 

12 after ‘‘House of Representatives’’. 

13 (d) POWERS OF DIRECTOR.—Section 704(d) is 

14 amended—

15 (1) in paragraph (9)—

16 (A) by inserting ‘‘notwithstanding any 

17 other provision of law,’’ after ‘‘(9)’’; and 

18 (B) by striking ‘‘Strategy; and’’ and insert19 ing ‘‘Strategy and notify the appropriate con20 gressional committees of any fund control no21 tice issued in accordance with section 

22 704(f)(5);’’; and 

23 (2) in paragraph (10), by inserting before the 

24 period the following: ‘‘and section 706 of the De-
13

•S 1860 IS 

1 partment of State Authorization Act for Fiscal Year 

2 2003 (22 U.S.C. 229j–1)’’. 

3 (e) FUND CONTROL NOTICES.—Section 704(f) is 

4 amended by adding at the end the following: 

5 ‘‘(4) CONGRESSIONAL NOTICE.—A copy of each 

6 fund control notice shall be transmitted to the ap7 propriate congressional committees. 

8 ‘‘(5) RESTRICTIONS.—The Director shall not 

9 issue a fund control notice to direct that all or part 

10 of an amount appropriated to the National Drug 

11 Control Program agency account be obligated, modi12 fied, or altered in any manner—

13 ‘‘(A) contrary, in whole or in part, to a 

14 specific appropriation; or 

15 ‘‘(B) contrary, in whole or in part, to the 

16 expressed intent of Congress.’’. 

17 (f) UNITED STATES INTERDICTION COORDINATOR.—

18 (1) IN GENERAL.—Section 704 is amended by 

19 adding at the end the following: 

20 ‘‘(i) UNITED STATES INTERDICTION COORDI21 NATOR.—

22 ‘‘(1) IN GENERAL.—There shall be a United 

23 States Interdiction Coordinator, who shall be des24 ignated by the Director and who shall be responsible 

25 for the coordination of interdiction operations among 
14

•S 1860 IS 

1 National Drug Control Program agencies to prevent 

2 and reduce the illegal importation of drugs into the 

3 United States. 

4 ‘‘(2) RESPONSIBILITIES.—The United States 

5 Interdiction Coordinator shall be responsible to the 

6 Director for—

7 ‘‘(A) coordinating National Drug Control 

8 Program agencies’ interdiction activities to en9 sure consistency with the National Drug Con10 trol Strategy; 

11 ‘‘(B) developing a National Drug Control 

12 Interdiction plan consistent with the National 

13 Drug Control Strategy; 

14 ‘‘(C) assessing the sufficiency of National 

15 Drug Control Program agencies’ assets com16 mitted to illicit drug interdiction; and 

17 ‘‘(D) advising the Director on the efforts 

18 of each National Drug Control Program agency 

19 to implement the National Drug Control Inter20 diction plan.’’. 

21 (2) AMENDMENT TO HOMELAND SECURITY ACT

22 OF 2002.—Section 878 of the Homeland Security Act 

23 of 2002 (6 U.S.C. 458) is amended by striking 

24 ‘‘shall—’’ through paragraph (2) and inserting 
15

•S 1860 IS 

1 ‘‘shall ensure the adequacy of resources within the 

2 Department for illicit drug interdiction.’’. 

3 SEC. 104. AMENDMENTS TO ENSURE COORDINATION WITH 

4 OTHER AGENCIES. 

5 Section 705 is amended—

6 (1) in subsection (a)(1)(A), by striking 

7 ‘‘abuse’’; 

8 (2) by amending subsection (a)(3) to read as 

9 follows: 

10 ‘‘(3) REQUIRED REPORTS.—

11 ‘‘(A) SECRETARIES OF THE INTERIOR AND

12 AGRICULTURE.—Not later than July 1 of each 

13 year, the Secretaries of Agriculture and the In14 terior shall jointly submit to the Director and 

15 the appropriate congressional committees an as16 sessment of the quantity of illegal drug cultiva17 tion and manufacturing in the United States on 

18 lands owned or under the jurisdiction of the 

19 Federal Government for the preceding year. 

20 ‘‘(B) SECRETARY OF HOMELAND SECU21 RITY.—Not later than July 1 of each year, the 

22 Secretary of Homeland Security shall submit to 

23 the Director and the appropriate congressional 

24 committees information for the preceding year 

25 regarding—
16

•S 1860 IS 

1 ‘‘(i) the number and type of seizures 

2 of drugs by each component of the Depart3 ment seizing drugs, as well as statistical 

4 information on the geographic areas of 

5 such seizures; and 

6 ‘‘(ii) the number of air and maritime 

7 patrol hours undertaken by each compo8 nent of the Department primarily dedi9 cated to drug supply reduction missions. 

10 ‘‘(C) SECRETARY OF DEFENSE.—The Sec11 retary of Defense shall, by July 1 of each year, 

12 submit to the Director and the appropriate con13 gressional committees information for the pre14 ceding year regarding the number of air and 

15 maritime patrol hours primarily dedicated to 

16 drug supply reduction missions undertaken by 

17 each component of the Department of De18 fense.’’; and 

19 (3) in subsection (b)(2)(B), by striking ‘‘Pro20 gram’’ and inserting ‘‘Strategy’’. 

21 TITLE II—THE NATIONAL DRUG 

22 CONTROL STRATEGY 

23 SEC. 201. ANNUAL PREPARATION AND SUBMISSION OF NA24 TIONAL DRUG CONTROL STRATEGY. 

25 Section 706 is amended to read as follows: 
17

•S 1860 IS 

1 ‘‘SEC. 706. DEVELOPMENT, SUBMISSION, IMPLEMENTATION, 

2 AND ASSESSMENT OF NATIONAL DRUG CON3 TROL STRATEGY. 

4 ‘‘(a) TIMING, CONTENTS, AND PROCESS FOR DEVEL5 OPMENT AND SUBMISSION OF NATIONAL DRUG CONTROL

6 STRATEGY.—

7 ‘‘(1) TIMING.—Not later than February 1st of 

8 each year, the President shall submit to Congress a 

9 National Drug Control Strategy, which shall set 

10 forth a comprehensive plan for the year to reduce 

11 drug abuse and the consequences of such drug abuse 

12 in the United States by limiting the availability of, 

13 and reducing the demand for, illegal drugs. 

14 ‘‘(2) CONTENTS.—

15 ‘‘(A) IN GENERAL.—The National Drug 

16 Control Strategy submitted under paragraph 

17 (1) shall include—

18 ‘‘(i) comprehensive, research-based, 

19 long range, quantifiable goals for reducing 

20 drug abuse and the consequences of drug 

21 abuse in the United States; 

22 ‘‘(ii) annual quantifiable and measur23 able objectives and specific targets to ac24 complish long-term quantifiable goals that 

25 the Director determines may be achieved 

26 during each year beginning on the date on 
18

•S 1860 IS 

1 which the National Drug Control Strategy 

2 is submitted; 

3 ‘‘(iii) 5-year projections for program 

4 and budget priorities; 

5 ‘‘(iv) a review of international, State, 

6 local, and private sector drug control ac7 tivities to ensure that the United States 

8 pursues coordinated and effective drug 

9 control at all levels of government; 

10 ‘‘(v) an assessment of current illicit 

11 drug use (including inhalants) and avail12 ability, impact of illicit drug use, and 

13 treatment availability, which assessment 

14 shall include—

15 ‘‘(I) estimates of drug prevalence 

16 and frequency of use as measured by 

17 national, State, and local surveys of il18 licit drug use and by other special 

19 studies of nondependent and depend20 ent illicit drug use; 

21 ‘‘(II) illicit drug use in the work22 place and the productivity lost by such 

23 use; and 

24 ‘‘(III) illicit drug use by 

25 arrestees, probationers, and parolees; 
19

•S 1860 IS 

1 ‘‘(vi) an assessment of the reduction 

2 of illicit drug availability, as measured 

3 by—

4 ‘‘(I) the quantities of cocaine, 

5 heroin, marijuana, methamphetamine, 

6 ecstasy, and other drugs available for 

7 consumption in the United States; 

8 ‘‘(II) the amount of marijuana, 

9 cocaine, heroin, methamphetamine, ec10 stasy, and precursor chemicals and 

11 other drugs entering the United 

12 States; 

13 ‘‘(III) the number of illicit drug 

14 manufacturing laboratories seized and 

15 destroyed and the number of hectares 

16 of marijuana, poppy, and coca cul17 tivated and destroyed domestically 

18 and in other countries; 

19 ‘‘(IV) the number of metric tons 

20 of marijuana, heroin, cocaine, and 

21 methamphetamine seized and other 

22 drugs; and 

23 ‘‘(V) changes in the price and 

24 purity of heroin, methamphetamine, 

25 and cocaine, changes in the price of 
20

•S 1860 IS 

1 ecstasy, and changes in 

2 tetrahydrocannabinol level of mari3 juana and other drugs; 

4 ‘‘(vii) an assessment of the reduction 

5 of the consequences of illicit drug use and 

6 availability, which shall include—

7 ‘‘(I) the burden illicit drug users 

8 placed on hospital emergency depart9 ments in the United States, such as 

10 the quantity of illicit drug-related 

11 services provided; 

12 ‘‘(II) the annual national health 

13 care cost of illicit drug use; and 

14 ‘‘(III) the extent of illicit drug15 related crime and criminal activity; 

16 ‘‘(viii) a determination of the status of 

17 drug treatment in the United States, by 

18 assessing—

19 ‘‘(I) public and private treatment 

20 utilization; and 

21 ‘‘(II) the number of illicit drug 

22 users the Director estimates meet di23 agnostic criteria for treatment; 

24 ‘‘(ix) a review of the research agenda 

25 of the Counter-Drug Technology Assess-
21

•S 1860 IS 

1 ment Center to reduce the availability and 

2 abuse of drugs; and 

3 ‘‘(x) a summary of the efforts made to 

4 coordinate with private sector entities to 

5 conduct private research and development 

6 of medications to treat addiction by—

7 ‘‘(I) screening chemicals for po8 tential therapeutic value; 

9 ‘‘(II) developing promising com10 pounds; 

11 ‘‘(III) conducting clinical trials; 

12 ‘‘(IV) seeking Food and Drug 

13 Administration approval for drugs to 

14 treat addiction; 

15 ‘‘(V) marketing the drug for the 

16 treatment of addiction; 

17 ‘‘(VI) urging physicians to use 

18 the drug in the treatment of addic19 tion; and 

20 ‘‘(VII) encouraging insurance 

21 companies to reimburse the cost of 

22 the drug for the treatment of addic23 tion. 

24 ‘‘(B) CLASSIFIED INFORMATION.—Any 

25 contents of the National Drug Control Strategy
22

•S 1860 IS 

1 that involves information properly classified 

2 under criteria established by an Executive order 

3 shall be presented to Congress separately from 

4 the rest of the National Drug Control Strategy. 

5 ‘‘(3) PROCESS FOR DEVELOPMENT AND SUB6 MISSION.—In developing and effectively imple7 menting the National Drug Control Strategy, the 

8 Director—

9 ‘‘(A) shall consult with—

10 ‘‘(i) the heads of the National Drug 

11 Control Program agencies; 

12 ‘‘(ii) Congress; 

13 ‘‘(iii) State and local officials; 

14 ‘‘(iv) private citizens and organiza15 tions with experience and expertise in de16 mand reduction; 

17 ‘‘(v) private citizens and organizations 

18 with experience and expertise in supply re19 duction; and 

20 ‘‘(vi) appropriate representatives of 

21 foreign governments; 

22 ‘‘(B) in satisfying the requirements of sub23 paragraph (A), shall ensure, to the maximum 

24 extent possible, that State and local officials 

25 and relevant private organizations commit to 
23

•S 1860 IS 

1 support and take steps to achieve the goals and 

2 objectives of the National Drug Control Strat3 egy; 

4 ‘‘(C) with the concurrence of the Attorney 

5 General, may require the El Paso Intelligence 

6 Center to undertake specific tasks or projects to 

7 support or implement the National Drug Con8 trol Strategy; and 

9 ‘‘(D) with the concurrence of the Director 

10 of Central Intelligence and the Attorney Gen11 eral, may request that the National Drug Intel12 ligence Center undertake specific tasks or 

13 projects to support or implement the National 

14 Drug Control Strategy. 

15 ‘‘(b) SUBMISSION OF REVISED STRATEGY.—The 

16 President may submit to Congress a revised National 

17 Drug Control Strategy that meets the requirements of this 

18 section—

19 ‘‘(1) at any time, upon a determination of the 

20 President, in consultation with the Director, that the 

21 National Drug Control Strategy in effect is not suf22 ficiently effective; or 

23 ‘‘(2) if a new President or Director takes of24 fice.’’. 
24

•S 1860 IS 

1 SEC. 202. PERFORMANCE MEASUREMENTS. 

2 Section 706 is amended by adding at the end the fol3 lowing: 

4 ‘‘(c) PERFORMANCE MEASUREMENT SYSTEM.—Not 

5 later than February 1st of each year, the Director shall 

6 submit to Congress as part of the National Drug Control 

7 Strategy, a description of a national drug control perform8 ance measurement system, that—

9 ‘‘(1) develops annual and 5-year performance 

10 measures and targets for each National Drug Con11 trol Strategy goal and objective established for re12 ducing drug use, availability, and the consequences 

13 of drug use; 

14 ‘‘(2) describes the sources of information and 

15 data that will be used for each performance measure 

16 incorporated into the performance measurement sys17 tem; 

18 ‘‘(3) identifies major programs and activities of 

19 the National Drug Control Program agencies that 

20 support the goals and annual objectives of the Na21 tional Drug Control Strategy; 

22 ‘‘(4) evaluates the contribution of demand re23 duction and supply reduction activities as defined in 

24 section 702 implemented by each National Drug 

25 Control Program agency in support of the National 

26 Drug Control Strategy; 
25

•S 1860 IS 

1 ‘‘(5) monitors consistency between the drug-re2 lated goals and objectives of the National Drug Con3 trol Program agencies and ensures that each agen4 cy’s goals and budgets support and are fully con5 sistent with the National Drug Control Strategy; 

6 and 

7 ‘‘(6) coordinates the development and imple8 mentation of national drug control data collection 

9 and reporting systems to support policy formulation 

10 and performance measurement, including an assess11 ment of—

12 ‘‘(A) the quality of current drug use meas13 urement instruments and techniques to measure 

14 supply reduction and demand reduction activi15 ties; 

16 ‘‘(B) the adequacy of the coverage of exist17 ing national drug use measurement instruments 

18 and techniques to measure the casual drug use 

19 population, the addicted drug user population, 

20 and groups that are at risk for drug use; 

21 ‘‘(C) the adequacy of the coverage of exist22 ing national treatment outcome monitoring sys23 tems to measure the effectiveness of drug abuse 

24 treatment in reducing drug use and criminal 
26

•S 1860 IS 

1 behavior during and after the completion of 

2 substance abuse treatment; and 

3 ‘‘(D) the actions the Director shall take to 

4 correct any deficiencies and limitations identi5 fied pursuant to subparagraphs (A) and (B) of 

6 this subsection. 

7 ‘‘(d) MODIFICATIONS.—A description of any modi8 fications made during the preceding year to the national 

9 drug performance measurement system described in sub10 section (c) shall be included in each report submitted 

11 under subsection (b).’’. 

12 TITLE III—HIGH INTENSITY 

13 DRUG TRAFFICKING AREAS 

14 PROGRAM AND COUNTER15 DRUG TECHNOLOGY ASSESS16 MENT CENTER 

17 SEC. 301. PURPOSE OF HIGH INTENSITY DRUG TRAF18 FICKING AREAS PROGRAM. 

19 Section 707(a) is amended—

20 (1) by striking ‘‘There is’’ and inserting the fol21 lowing: 

22 ‘‘(1) IN GENERAL.—There is’’; and 

23 (2) by adding at the end the following: 

24 ‘‘(2) PURPOSE.—The purpose of the High In25 tensity Drug Trafficking Areas program is to reduce
27

•S 1860 IS 

1 drug trafficking and drug production in designated 

2 areas in the United States by—

3 ‘‘(A) facilitating cooperation among Fed4 eral, State, and local law enforcement agencies 

5 to share information and implement coordinated 

6 enforcement activities; 

7 ‘‘(B) enhancing intelligence sharing among 

8 Federal, State, and local law enforcement agen9 cies; 

10 ‘‘(C) providing reliable intelligence to law 

11 enforcement agencies needed to design effective 

12 enforcement strategies and operations; and 

13 ‘‘(D) supporting coordinated law enforce14 ment strategies which maximize use of available 

15 resources to reduce the supply of illegal drugs 

16 in HIDTA designated areas.’’. 

17 SEC. 302. DESIGNATION OF HIDTAS AND EVALUATION OF 

18 HIDTA PERFORMANCE. 

19 (a) CONSULTATION.—Section 707(b) is amended by 

20 striking ‘‘Secretary of the Treasury,’’ and inserting ‘‘the 

21 Secretary of Homeland Security,’’. 

22 (b) FACTORS FOR CONSIDERATION.—Section 707(c) 

23 is amended—

24 (1) in paragraph (1), by inserting ‘‘significant’’ 

25 before ‘‘center’’; and 
28

•S 1860 IS 

1 (2) by striking paragraph (3) and inserting the 

2 following: 

3 ‘‘(3) drug-related production, manufacturing, 

4 importation, or distribution in the area is having a 

5 significant harmful local or regional impact; and’’. 

6 (c) EVALUATION OF HIDTA PERFORMANCE.—Sec7 tion 707 is amended by adding at the end the following: 

8 ‘‘(e) EVALUATION.—

9 ‘‘(1) INITIAL REPORT.—Not later than 90 days 

10 after enactment of the Office of National Drug Con11 trol Policy Reauthorization Act of 2003, the Direc12 tor shall, after consulting with the Executive Boards 

13 of each designated HIDTA, submit a report to Con14 gress which describes, for each designated HIDTA—

15 ‘‘(A) the specific purposes for the HIDTA; 

16 ‘‘(B) the specific long-term and short-term 

17 goals and objectives for the HIDTA; 

18 ‘‘(C) the measurements which will be used 

19 to evaluate the performance of the HIDTA in 

20 achieving the long-term and short-term goals; 

21 and 

22 ‘‘(D) the reporting requirements needed to 

23 evaluate the performance of the HIDTA in 

24 achieving the long-term and short-term goals. 
29

•S 1860 IS 

1 ‘‘(2) EVALUATION OF HIDTA PROGRAM AS PART

2 OF NATIONAL DRUG CONTROL STRATEGY.—For each 

3 designated HIDTA, the Director shall submit, as 

4 part of the annual National Drug Control Strategy, 

5 a report that— 

6 ‘‘(A) describes—

7 ‘‘(i) the specific purposes for the 

8 HIDTA; and 

9 ‘‘(ii) the specific long-term and short10 term goals and objectives for the HIDTA; 

11 and 

12 ‘‘(B) includes an evaluation of the per13 formance of the each HIDTA in accomplishing 

14 the specific long-term and short-term goals and 

15 objectives identified under paragraph (1)(B).’’. 

16 SEC. 303. ORGANIZATION OF HIDTAS. 

17 Section 707 is amended by adding at the end the fol18 lowing: 

19 ‘‘(f) ORGANIZATION OF HIDTAS.—

20 ‘‘(1) EXECUTIVE BOARD AND OFFICERS.—Each 

21 HIDTA shall be governed by an Executive Board. 

22 The Executive Board shall designate a President, 

23 Vice President, and any other officers to the Board 

24 that it determines is necessary. 
30

•S 1860 IS 

1 ‘‘(2) MEMBERSHIP.—The membership of the 

2 Board shall consist of—

3 ‘‘(A) an equal number of representatives 

4 from—

5 ‘‘(i) Federal law enforcement; and 

6 ‘‘(ii) State and local law enforcement; 

7 and 

8 ‘‘(B) any other representative the Board 

9 determines would be appropriate. 

10 ‘‘(3) RESPONSIBILITIES.—The Executive Board 

11 shall be responsible for—

12 ‘‘(A) taking all necessary actions to ensure 

13 that the mission of the HIDTA is achieved; 

14 ‘‘(B) managing the HIDTA; 

15 ‘‘(C) reviewing and approving all funding 

16 proposals consistent with the overall objective of 

17 the HIDTA; and 

18 ‘‘(D) preparing and reviewing all reports to 

19 the Director on the HIDTA’s activities.’’. 

20 SEC. 304. HIDTA FUNDING. 

21 Section 707 is amended by adding at the end the fol22 lowing: 

23 ‘‘(g) FUNDING.—
31

•S 1860 IS 

1 ‘‘(1) APPROPRIATIONS.—There are authorized 

2 to be appropriated for funding activities of high in3 tensity drug trafficking areas under this section—

4 ‘‘(A) $280,000,000 for fiscal year 2004; 

5 ‘‘(B) $290,000,000 for fiscal years 2005 

6 and 2006; and 

7 ‘‘(C) $300,000,000 for fiscal years 2007 

8 and 2008. 

9 ‘‘(2) ANNUAL HIDTA PROGRAM BUDGET SUB10 MISSIONS.—As part of the documentation that sup11 ports the President’s annual budget request for the 

12 Office, the Director shall submit to Congress a 

13 budget justification that includes the following: 

14 ‘‘(A) The amount requested for each 

15 HIDTA with supporting narrative descriptions 

16 and rationale for each request. 

17 ‘‘(B) A detailed justification for each fund18 ing request which explains the reasons for the 

19 requested funding level, how such funding level 

20 was determined based on a current assessment 

21 of the drug trafficking threat in each HIDTA, 

22 and how such funding will ensure that the goals 

23 and objectives of each HIDTA will be achieved. 

24 ‘‘(3) EMERGING THREAT RESPONSE FUND.—

25 The Director may request not more than 10 percent
32

•S 1860 IS 

1 above the total requested funding for all HIDTAs 

2 for discretionary grants. Such funds may be used to 

3 respond to any emerging drug trafficking threat in 

4 an existing HIDTA, or to establish a new high in5 tensity trafficking area in accordance with the provi6 sions outlined in this Act.’’. 

7 SEC. 305. ASSESSMENT OF TASK FORCES IN HIDTA AREAS. 

8 Not later than 180 days after the date of enactment 

9 of this Act, the Director shall submit to Congress a re10 port—

11 (1) assessing the number and operation of all 

12 task forces within each HIDTA; and 

13 (2) describing—

14 (A) each Federal, State, and/or local task 

15 force operating in the HIDTA; 

16 (B) how the task forces coordinate with 

17 each other, with any HIDTA task force, and 

18 with Organized Crime and Drug Enforcement 

19 Task Force investigations; 

20 (C) what steps, if any, each task force 

21 takes to share information with other task 

22 forces in the HIDTA area; 

23 (D) the role of the HIDTA in coordinating 

24 the sharing of such information among task 

25 forces; 
33

•S 1860 IS 

1 (E) the nature and extent of cooperation 

2 by each Federal, State, and local participant in 

3 ensuring that information is shared among law 

4 enforcement agencies and with the HIDTA; 

5 (F) the nature and extent to which such 

6 information and enforcement activities are co7 ordinated with Joint Terrorism Task Forces in 

8 the HIDTA area; and 

9 (G) any recommendations for measures 

10 needed to ensure that task force resources are 

11 utilized efficiently and effectively to reduce the 

12 availability of illegal drugs in the HIDTA areas. 

13 SEC. 306. FUNDING FOR CERTAIN HIGH INTENSITY DRUG 

14 TRAFFICKING AREAS. 

15 (a) SHORT TITLE.—This section may be cited as the 

16 ‘‘Dawson Family Community Protection Act’’. 

17 (b) FINDINGS.—Congress finds the following: 

18 (1) In the early morning hours of October 16, 

19 2002, the home of Carnell and Angela Dawson was 

20 firebombed in apparent retaliation for Mrs. 

21 Dawson’s notification of police about persistent drug 

22 distribution activity in their East Baltimore City 

23 neighborhood. 

24 (2) The arson claimed the lives of Mr. and Mrs. 

25 Dawson and their 5 young children, aged 9 to 14. 
34

•S 1860 IS 

1 (3) The horrific murder of the Dawson family 

2 is a stark example of domestic narco-terrorism. 

3 (4) In all phases of counter-narcotics law en4 forcement—from prevention to investigation to pros5 ecution to reentry—the voluntary cooperation of or6 dinary citizens is a critical component. 

7 (5) Voluntary cooperation is difficult for law en8 forcement officials to obtain when citizens feel that 

9 cooperation carries the risk of violent retaliation by 

10 illegal drug trafficking organizations and their affili11 ates. 

12 (6) Public confidence that law enforcement is 

13 doing all it can to make communities safe is a pre14 requisite for voluntary cooperation among people 

15 who may be subject to intimidation or reprisal (or 

16 both). 

17 (7) Witness protection programs are insufficient 

18 on their own to provide security because many indi19 viduals and families who strive every day to make 

20 distressed neighborhoods livable for their children, 

21 other relatives, and neighbors will resist or refuse of22 fers of relocation by Federal, State, and local pros23 ecutorial agencies and because, moreover, the contin24 ued presence of strong individuals and families is 
35

•S 1860 IS 

1 critical to preserving and strengthening the social 

2 fabric in such communities. 

3 (8) Where (as in certain sections of Baltimore 

4 City) interstate trafficking of illegal drugs has severe 

5 ancillary local consequences within areas designated 

6 as high intensity drug trafficking areas, it is impor7 tant that supplementary High Intensity Drug Traf8 ficking Areas Program funds be committed to sup9 port initiatives aimed at making the affected com10 munities safe for the residents of those communities 

11 and encouraging their cooperation with Federal, 

12 State, and local law enforcement efforts to combat 

13 illegal drug trafficking. 

14 (c) FUNDING FOR CERTAIN HIGH INTENSITY DRUG

15 TRAFFICKING AREAS.—Section 707(h) (21 U.S.C. 1706) 

16 is amended by adding at the end the following: 

17 ‘‘(6) SPECIFIC PURPOSES.—

18 ‘‘(A) IN GENERAL.—The Director shall en19 sure that, of the amounts appropriated for a 

20 fiscal year for the Program, at least $1,000,000 

21 is used in high intensity drug trafficking areas 

22 with severe neighborhood safety and illegal drug 

23 distribution problems. 

24 ‘‘(B) REQUIRED USES.—The funds used 

25 under subparagraph (A) shall be used—
36

•S 1860 IS 

1 ‘‘(i) to ensure the safety of neighbor2 hoods and the protection of communities, 

3 including the prevention of the intimida4 tion of potential witnesses of illegal drug 

5 distribution and related activities; and 

6 ‘‘(ii) to combat illegal drug trafficking 

7 through such methods as the Director con8 siders appropriate, such as establishing or 

9 operating (or both) a toll-free telephone 

10 hotline for use by the public to provide in11 formation about illegal drug-related activi12 ties.’’. 

13 SEC. 307. REPORT ON INTELLIGENCE SHARING. 

14 Not later than 180 days after the date of enactment 

15 of this Act, the Director shall submit to Congress a re16 port—

17 (1) evaluating existing and planned intelligence 

18 systems used by Federal, State, and local law en19 forcement agencies responsible for drug trafficking 

20 and drug production enforcement; and 

21 (2) addressing—

22 (A) the current intelligence systems used 

23 by Federal, State, and local law enforcement 

24 agencies;
37

•S 1860 IS 

1 (B) the compatibility of such systems in 

2 ensuring access and availability of intelligence 

3 to Federal, State, and local law enforcement; 

4 (C) the extent to which Federal, State, and 

5 local law enforcement are sharing intelligence 

6 information to assess current threats and de7 sign appropriate enforcement strategies; and 

8 (D) the measures needed to ensure and to 

9 promote effective information sharing among 

10 intelligence systems operated by Federal, State, 

11 and local law enforcement agencies responsible 

12 for drug trafficking and drug production en13 forcement. 

14 SEC. 308. COUNTER-DRUG TECHNOLOGY ASSESSMENT CEN15 TER. 

16 (a) CHIEF SCIENTIST.—Section 708(b) is amended 

17 to read as follows: 

18 ‘‘(b) CHIEF SCIENTIST.—There shall be at the head 

19 of the Center the Chief Scientist, who shall be appointed 

20 by the Director from among individuals qualified and dis21 tinguished in the area of science, medicine, engineering, 

22 or technology.’’. 

23 (b) RESPONSIBILITIES.—

24 (1) RESEARCH AND DEVELOPMENT.—Section 

25 708 is amended by—
38

•S 1860 IS 

1 (A) redesignating subsection (d) as sub2 section (e); and 

3 (B) striking subsection (c) and inserting 

4 the following: 

5 ‘‘(c) RESEARCH AND DEVELOPMENT RESPONSIBIL6 ITIES.—The Chief Scientist shall be responsible to the Di7 rector for—

8 ‘‘(1) identifying and defining the short-, me9 dium-, and long-term scientific and technological 

10 needs of Federal, State, and local drug supply re11 duction agencies, including—

12 ‘‘(A) advanced surveillance, tracking, and 

13 radar imaging; 

14 ‘‘(B) electronic support measures; 

15 ‘‘(C) communications; 

16 ‘‘(D) data fusion, advanced computer sys17 tems, and artificial intelligence; and 

18 ‘‘(E) chemical, biological, radiological (in19 cluding neutron and electron), and other means 

20 of detection; 

21 ‘‘(2) identifying demand reduction basic and 

22 applied research needs and initiatives, in consulta23 tion with affected National Drug Control Program 

24 agencies, including—
39

•S 1860 IS 

1 ‘‘(A) improving treatment through 

2 neuroscientific advances; 

3 ‘‘(B) improving the transfer of biomedical 

4 research to the clinical setting; and 

5 ‘‘(C) in consultation with the National In6 stitute of Drug Abuse, and through interagency 

7 agreements or grants, examining addiction and 

8 rehabilitation research and the application of 

9 technology to expanding the effectiveness of 

10 availability of drug treatment; 

11 ‘‘(3) making a priority ranking of such needs 

12 identified in paragraphs (1) and (2) according to fis13 cal and technological feasibility, as part of a Na14 tional Counter-Drug Research and Development 

15 Program; 

16 ‘‘(4) overseeing and coordinating counter-drug 

17 technology initiatives with related activities of other 

18 Federal civilian and military departments; 

19 ‘‘(5) providing support to the development and 

20 implementation of the national drug control per21 formance measurement system established under 

22 subsection (c) of section 706; and 

23 ‘‘(6) transferring funds made available to a Na24 tional Drug Control Program agency for counter25 drug technology research and development to an-
40

•S 1860 IS 

1 other account within such agency or to another Na2 tional Drug Control Program agency for counter3 drug technology research and development, pursuant 

4 to the authority of the Director under section 704. 

5 ‘‘(d) LIMITATION ON AUTHORITY.—The authority 

6 granted to the Director under this section shall not extend 

7 to the awarding of contracts, management of individual 

8 projects, or other operational activities.’’. 

9 (2) ASSISTANCE AND SUPPORT.—Subsection (e) 

10 of section 708, as redesignated by this section, is 

11 amended to read as follows: 

12 ‘‘(e) ASSISTANCE AND SUPPORT TO THE OFFICE OF

13 NATIONAL DRUG CONTROL POLICY.—The Secretary of 

14 Defense, the Secretary of Homeland Security, and the 

15 Secretary of Health and Human Services shall, to the 

16 maximum extent practicable, render assistance and sup17 port to the Office and to the Director in the conduct of 

18 Counterdrug technology assessment.’’. 

19 (3) TECHNOLOGY TRANSFER PROGRAM.—Sec20 tion 708 is amended by adding at the end the fol21 lowing: 

22 ‘‘(f) TECHNOLOGY TRANSFER PROGRAM.—

23 ‘‘(1) PROGRAM.—The Chief Scientist, with the 

24 advice and counsel of experts from State and local 

25 law enforcement agencies, shall be responsible to the 
41

•S 1860 IS 

1 Director for coordination and implementation of a 

2 counter-drug technology transfer program. 

3 ‘‘(2) PURPOSE.—The purpose of the Tech4 nology Transfer Program shall be for the 

5 Counterdrug Technology Assessment Center to 

6 transfer technology and associated training directly 

7 to State and local law enforcement agencies. 

8 ‘‘(3) PRIORITY OF RECEIPTS.—Transfers shall 

9 be made in priority order based on—

10 ‘‘(A) the need of potential recipients for 

11 such technology; 

12 ‘‘(B) the effectiveness of the technology to 

13 enhance current counter-drug activities of po14 tential recipients; and 

15 ‘‘(C) the ability and willingness of potential 

16 recipients to evaluate transferred technology. 

17 ‘‘(4) AGREEMENT AUTHORITY.—The Director 

18 may enter into an agreement with the Secretary of 

19 Homeland Security to transfer technology with both 

20 counter-drug and homeland security applications to 

21 State and local law enforcement agencies on a reim22 bursable basis. 

23 ‘‘(5) REPORT.—On or before July 1 of each 

24 year, the Director shall submit a report to the ap-
42

•S 1860 IS 

1 propriate congressional committees which addresses 

2 the following: 

3 ‘‘(A) The number of requests received dur4 ing the previous 12 months. 

5 ‘‘(B) The number of requests fulfilled dur6 ing the previous 12 months. 

7 ‘‘(C) A summary of the criteria used in 

8 making the determination on what requests 

9 were funded and what requests were not fund10 ed. 

11 ‘‘(D) A general assessment of the future 

12 needs of the program, based on expected 

13 changes in threats, expected technologies, and 

14 likely need from potential recipients. 

15 ‘‘(E) An assessment of the effectiveness of 

16 the technologies transferred, based in part on 

17 the evaluations provided by the recipients, with 

18 a recommendation whether the technology 

19 should continue to be offered through the pro20 gram.’’.
43

•S 1860 IS 

1 TITLE IV—REAUTHORIZATION 

2 AND IMPROVEMENT OF THE 

3 NATIONAL ANTI-DRUG MEDIA 

4 CAMPAIGN 

5 SEC. 401. SHORT TITLE. 

6 This title may be cited as the ‘‘National Youth Anti7 Drug Media Campaign Reauthorization Act of 2003’’. 

8 SEC. 402. PURPOSES OF THE NATIONAL ANTI-DRUG MEDIA 

9 CAMPAIGN. 

10 The Drug-Free Media Campaign Act of 1998 (21 

11 U.S.C. 1801 et seq.) is amended—

12 (1) in section 101, by striking ‘‘Drug-Free 

13 Media Campaign Act of 1998’’ and inserting ‘‘Na14 tional Youth Anti-Drug Media Campaign Act’’; and 

15 (2) in section 102—

16 (A) in subsection (a), by striking ‘‘national 

17 media campaign’’ and all that follows through 

18 the period and inserting the following: ‘‘national 

19 youth anti-drug media campaign (referred to in 

20 this subtitle as the ‘national media campaign’) 

21 in accordance with this subtitle for the purposes 

22 of—

23 ‘‘(1) preventing drug abuse among young peo24 ple in the United States; 
44

•S 1860 IS 

1 ‘‘(2) increasing awareness of adults of the im2 pact of drug abuse on young people; and 

3 ‘‘(3) encouraging parents and other interested 

4 adults to discuss with young people the dangers of 

5 illegal drug use.’’; and 

6 (B) in subsection (b), by striking ‘‘105’’ 

7 and inserting ‘‘106’’. 

8 SEC. 403. ROLES AND RESPONSIBILITIES OF THE DIREC9 TOR, THE PARTNERSHIP FOR A DRUG-FREE 

10 AMERICA, AND A MEDIA BUYING CON11 TRACTOR. 

12 The Drug-Free Media Campaign Act of 1998 (21 

13 U.S.C. 1801 et seq.) is amended—

14 (1) by adding at the end the following: 

15 ‘‘(c) DIVISION OF RESPONSIBILITIES AND FUNC16 TIONS UNDER THE PROGRAM.—

17 ‘‘(1) IN GENERAL.—The Director, in consulta18 tion with the Partnership for a Drug-Free America, 

19 shall determine the overall purposes and strategy of 

20 the national media campaign. 

21 ‘‘(2) RESPONSIBILITIES.—

22 ‘‘(A) DIRECTOR.—The Director shall be 

23 responsible for implementing a focused national 

24 media campaign to meet the purposes set forth 

25 in section 102(a), and shall approve—
45

•S 1860 IS 

1 ‘‘(i) the strategy of the national media 

2 campaign; 

3 ‘‘(ii) all advertising and promotional 

4 material used in the national media cam5 paign; and 

6 ‘‘(iii) the plan for the purchase of ad7 vertising time and space for the national 

8 media campaign. 

9 ‘‘(B) THE PARTNERSHIP FOR A DRUG10 FREE AMERICA.—The Director shall request 

11 that the Partnership for a Drug-Free Amer12 ica—

13 ‘‘(i) develop and recommend strategies 

14 to achieve the goals of the national media 

15 campaign that address national and local 

16 drug threats in specific regions or States, 

17 such as methamphetamine and ecstasy; 

18 ‘‘(ii) create all advertising to be used 

19 in the national media campaign, except ad20 vertisements that are—

21 ‘‘(I) provided by other nonprofit 

22 entities pursuant to section 103(c); 

23 ‘‘(II) intended to reach a minor24 ity, ethnic, or other special audience 

25 that cannot be obtained at no cost 
46

•S 1860 IS 

1 (not including production costs and 

2 talent reuse payments), provided that 

3 any such advertising material is re4 viewed and approved by the Partner5 ship for a Drug-Free America; and 

6 ‘‘(III) any other advertisements 

7 that the Partnership for a Drug-Free 

8 America determines it is unable to 

9 provide; 

10 ‘‘(C) MEDIA BUYING CONTRACTOR.—The 

11 Director shall enter into a contract with a 

12 media buying contractor to plan and purchase 

13 advertising time and space for the national 

14 media campaign. The media buying contractor 

15 shall not provide any service or material, or 

16 conduct any function or activity which can be 

17 provided by the Partnership for a Drug Free 

18 America’’; and 

19 (2) in section 103— 

20 (A) in subparagraph (A), by inserting ‘‘, 

21 including the strategic planning for, and ac22 counting of, such purchases’’ after ‘‘space’’; 

23 (B) in subparagraph (C), by striking ‘‘out24 of-pocket’’; and 
47

•S 1860 IS 

1 (C) in subparagraph (F), by striking ‘‘the 

2 Office of National Drug Control Policy’’ and in3 serting ‘‘either the Office of National Drug 

4 Control Policy or the designee of the Office’’. 

5 SEC. 404. RESPONSIBLE USE OF FEDERAL FUNDS FOR THE 

6 NATIONAL ANTI-DRUG MEDIA CAMPAIGN. 

7 The Drug-Free Media Campaign Act of 1998 (21 

8 U.S.C. 1801 et seq.) is amended—

9 (1) in section 103, by striking paragraph (2) 

10 and inserting the following: 

11 ‘‘(2) ADVERTISING.—

12 ‘‘(A) IN GENERAL.—Except as provided in 

13 subparagraph (B), in carrying out this subtitle, 

14 the Director shall ensure that sufficient funds 

15 are allocated to meet the stated goals of the na16 tional media campaign. 

17 ‘‘(B) EXCEPTION.—No funds shall be used 

18 for the creative development of advertisements 

19 (not including out-of-pocket production costs 

20 and talent reuse payments) except when—

21 ‘‘(i) the advertisements are intended 

22 to reach a minority, ethnic, or other special 

23 audience that cannot be obtained at no 

24 cost (not including production costs and 

25 talent reuse payments);
48

•S 1860 IS 

1 ‘‘(ii) the Partnership for a Drug-Free 

2 America is unable to provide such adver3 tisements; and 

4 ‘‘(iii) the Director receives prior ap5 proval from the appropriate congressional 

6 committees.’’; 

7 (2) in subsection (b), by striking ‘‘105’’ and in8 serting ‘‘106’’; 

9 (3) by striking subsection (c) and inserting the 

10 following: 

11 ‘‘(c) MATCHING REQUIREMENT.—

12 ‘‘(1) NO COST MATCH.—

13 ‘‘(A) IN GENERAL.—Except as provided in 

14 subparagraph (B), amounts made available for 

15 the national media campaign under section 106 

16 shall be used to require a no cost match of 

17 equivalent value of advertising broadcast time, 

18 print space, or in-kind contributions to the na19 tional media campaign, prior to the Director 

20 executing a contract for the purchase of any ad21 vertising time or space for the national media 

22 campaign. 

23 ‘‘(B) EXCEPTION.—The Director shall en24 sure that all no cost matches of advertising ma25 terial, time, space, or in-kind contributions pro-
49

•S 1860 IS 

1 vided pursuant to subparagraph (A) directly re2 late to substance abuse prevention and specifi3 cally promote the specific purposes set forth in 

4 section 102(a). 

5 ‘‘(2) SPONSORSHIP IDENTIFICATION.—Any ad6 vertising material donated to the national media 

7 campaign at no cost shall not be subject to the spon8 sorship identification provisions in section 317 of the 

9 Communications Act of 1934 (47 U.S.C. 317).’’; 

10 (4) by adding at the end the following: 

11 ‘‘(d) RESPONSIBLE USE OF FEDERAL FUNDS.—

12 ‘‘(1) IN GENERAL.—The Director shall ensure 

13 that—

14 ‘‘(A) for each fiscal year, not less than 85 

15 percent of the amounts appropriated under this 

16 subtitle shall be used for the purchase of adver17 tising time and space for the national media 

18 campaign; 

19 ‘‘(B) no Federal funds are used to pay any 

20 entity for any activity or service that duplicates, 

21 in whole or in part, any material, function, ac22 tivity, or service provided by the Partnership 

23 for a Drug-Free America; 
50

•S 1860 IS 

1 ‘‘(C) no more than $5,000,000 is used in 

2 each fiscal year to develop advertising material 

3 pursuant to subsection (a)(2)(B)(ii); and 

4 ‘‘(D) a corporation, partnership, or indi5 vidual, shall not be considered a bidder for a 

6 contract under this subtitle if such corporation, 

7 partnership, or individual has, within the pre8 vious 10-year period, in connection with the na9 tional media campaign—

10 ‘‘(i) been convicted of any Federal 

11 criminal offense; 

12 ‘‘(ii) been subject to any Federal civil 

13 judgment or penalty in a civil proceeding 

14 instituted by the United States; or 

15 ‘‘(iii) settled any Federal civil pro16 ceeding or potential proceeding instituted 

17 by the United States. 

18 ‘‘(2) NEW CONTRACT.—Notwithstanding any 

19 other provision of law, if a corporation, partnership, 

20 or individual does not qualify for consideration 

21 under paragraph (1)(B), then not later than 90 days 

22 after the date of enactment of the National Youth 

23 Anti-Drug Media Campaign Reauthorization Act of 

24 2003, the Director shall—
51

•S 1860 IS 

1 ‘‘(A) terminate any existing contract prior 

2 to the expiration; or 

3 ‘‘(B) prior to exercising any option to ex4 tend or to renew any contract that is in effect 

5 on the date of introduction of the National 

6 Youth Anti-Drug Media Campaign Reauthoriza7 tion Act of 2003, publish a notice of solicitation 

8 of bids for a new contract for the purchase of 

9 advertising time and space, provided that termi10 nation of the existing contract and any solicita11 tion of a new contract shall be carried out in 

12 a manner to ensure that the national media 

13 campaign is not interrupted until the execution 

14 of the new contract. 

15 ‘‘(3) CONGRESSIONAL NOTIFICATION.—Prior to 

16 entering into a contract for the purchase of adver17 tising time and space in accordance with this sub18 section, the Director shall notify appropriate con19 gressional committees.’’; 

20 (5) by striking section 104 and inserting the 

21 following: 

22 ‘‘SEC. 104. FINANCIAL AND PERFORMANCE ACCOUNT23 ABILITY. 

24 ‘‘The Director shall—
52

•S 1860 IS 

1 ‘‘(1) carry out (through the Defense Contract 

2 Audit Agency or an independent auditor) an exam3 ination of records as described in section 304C of 

4 the Federal Property and Administrative Services 

5 Act of 1949 (41 U.S.C. 254d) and an audit of the 

6 costs described in section 306 of that Act (41 U.S.C. 

7 256); 

8 ‘‘(2) annually evaluate the effectiveness of the 

9 national media campaign based on—

10 ‘‘(A) the ‘Monitoring the Future Study’ 

11 published by the Department of Health and 

12 Human Services; 

13 ‘‘(B) the Attitude Tracking Study pub14 lished by the Partnership for a Drug-Free 

15 America; and 

16 ‘‘(C) other relevant studies or publications, 

17 as determined by the Director, including track18 ing and evaluation data collected according to 

19 marketing and advertising industry standards; 

20 and 

21 ‘‘(3) submit a report to Congress in accordance 

22 with section 105, including the evaluation referred to 

23 in paragraph (2).’’; and 

24 (6) by striking section 105 and inserting the 

25 following:
53

•S 1860 IS 

1 ‘‘SEC. 105. REPORT TO CONGRESS. 

2 ‘‘The Director shall annually submit a report to Con3 gress that describes—

4 ‘‘(1) the strategy of the national media cam5 paign and whether specific objectives of the cam6 paign were accomplished; 

7 ‘‘(2) steps taken to ensure that the national 

8 media campaign operates in an effective and effi9 cient manner consistent with the overall strategy 

10 and focus of the campaign; 

11 ‘‘(3) plans to purchase advertising time and 

12 space; 

13 ‘‘(4) policies and practices implemented to en14 sure that Federal funds are used responsibly to pur15 chase advertising time and space and eliminate the 

16 potential for waste, fraud, and abuse; 

17 ‘‘(5) all contracts entered into with a corpora18 tion, partnership, or individual working on behalf of 

19 the national media campaign; 

20 ‘‘(6) specific policies and steps implemented to 

21 ensure compliance with this subtitle; 

22 ‘‘(7) steps taken to ensure that the national 

23 media campaign will secure, to the maximum extent 

24 possible, no cost matches of advertising time and 

25 space or in-kind contributions that are directly re-
54

•S 1860 IS 

1 lated to the campaign in accordance with this sub2 title; and 

3 ‘‘(8) a review and evaluation of the effectiveness 

4 of the national media campaign strategy for the past 

5 year.’’. 

6 SEC. 405. GAO AUDIT OF NATIONAL MEDIA CAMPAIGN. 

7 (a) IN GENERAL.—Not later than 1 year after the 

8 date of enactment of this Act, the General Accounting Of9 fice shall report to Congress on the national media cam10 paign. 

11 (b) CONTENTS.—The report described in subsection 

12 (a) shall include information an assessment of—

13 (1) the strategy, objectives and policies and 

14 practices of the campaign; 

15 (2) the Office’s management and strategic focus 

16 on the campaign; 

17 (3) the steps taken to ensure that the campaign 

18 operates effectively and minimizes the potential for 

19 waste, fraud, and abuse. 

20 (4) the roles of the Office, the Partnership for 

21 a Drug Free America, and the Media Buying Con22 tractor, and the coordination of their efforts; 

23 (5) the existence, if any, of any duplication of 

24 roles and responsibilities between the Partnership 
55

•S 1860 IS 

1 for a Drug Free America and the Media Buying 

2 Contractor; 

3 (6) the policies and practices for supervising 

4 contractors who assist in the national media cam5 paign; 

6 (7) the manner in which advertising time and 

7 space and no-cost matches are obtained; 

8 (8) the coordination of the national media cam9 paign among different media outlets; and 

10 (9) potential reforms to the management and 

11 operation of the national media campaign to ensure 

12 that the campaign operates effectively and effi13 ciently. 

14 SEC. 406. AUTHORIZATION FOR NATIONAL MEDIA CAM15 PAIGN. 

16 The Drug-Free Media Campaign Act of 1998 (21 

17 U.S.C. 1801 et seq) is amended by adding at the end the 

18 following: 

19 ‘‘SEC. 106. AUTHORIZATION OF APPROPRIATIONS. 

20 ‘‘There is authorized to be appropriated to the Office 

21 of National Drug Control Policy to carry out this subtitle, 

22 $195,000,000 for each of the fiscal years 2004 through 

23 2008.’’. 
56

•S 1860 IS 

1 TITLE V—AUTHORIZATIONS AND 

2 EXTENSION OF TERMINATION 

3 DATE 

4 SEC. 501. AUTHORIZATION OF APPROPRIATIONS. 

5 Section 714 is amended—

6 (1) by striking ‘‘title,’’ and inserting ‘‘title ex7 cept activities otherwise specified,’’; and 

8 (2) by striking ‘‘1999 through 2003’’ and in9 serting ‘‘2004 through 2008’’. 

10 SEC. 502. EXTENSION OF TERMINATION DATE. 

11 Section 715(a) is amended by striking ‘‘September 

12 30, 2003, this title and the amendments made by this 

13 title’’ and inserting ‘‘September 30, 2008, this title and 

14 the amendments made to this title’’. 

15 TITLE VI—DESIGNATION OF 

16 UNITED STATES ANTI-DOPING 

17 AGENCY 

18 SEC. 601. DESIGNATION OF UNITED STATES ANTI-DOPING 

19 AGENCY. 

20 (a) DEFINITIONS.—In this title: 

21 (1) UNITED STATES OLYMPIC COMMITTEE.—

22 The term ‘‘United States Olympic Committee’’ 

23 means the organization established by the ‘‘Ted Ste24 vens Olympic and Amateur Sports Act’’ (36 U.S.C. 

25 220501 et seq.). 
57

•S 1860 IS 

1 (2) AMATEUR ATHLETIC COMPETITION.—The 

2 term ‘‘amateur athletic competition’’ means a con3 test, game, meet, match, tournament, regatta, or 

4 other event in which amateur athletes compete (36 

5 U.S.C. 220501(b)(2)). 

6 (3) AMATEUR ATHLETE.—The term ‘‘amateur 

7 athlete’’ means an athlete who meets the eligibility 

8 standards established by the national governing body 

9 or paralympic sports organization for the sport in 

10 which the athlete competes (36 U.S.C. 22501(b)(1)). 

11 (b) IN GENERAL.—The United States Anti-Doping 

12 Agency shall—

13 (1) serve as the independent anti-doping organi14 zation for the amateur athletic competitions recog15 nized by the United States Olympic Committee; 

16 (2) ensure that athletes participating in ama17 teur athletic activities recognized by the United 

18 States Olympic Committee are prevented from using 

19 performance-enhancing drugs; 

20 (3) implement anti-doping education, research, 

21 testing, and adjudication programs to prevent 

22 United States Amateur Athletes participating in any 

23 activity recognized by the United States Olympic 

24 Committee from using performance-enhancing 

25 drugs; and
58

•S 1860 IS 

1 (4) serve as the United States representative 

2 responsible for coordination with other anti-doping 

3 organizations coordinating amateur athletic competi4 tions recognized by the United States Olympic Com5 mittee to ensure the integrity of athletic competition, 

6 the health of the athletes and the prevention of use 

7 of performance-enhancing drugs by United States 

8 amateur athletes. 

9 SEC. 602. AUTHORIZATION OF APPROPRIATIONS. 

10 There are authorized to be appropriated to the 

11 United States Anti-Doping Agency—

12 (1) for fiscal year 2004, $7,200,000; 

13 (2) for fiscal year 2005, $9,200,000; 

14 (3) for fiscal year 2006, $9,500,000; 

15 (4) for fiscal year 2007, $9,900,000; and 

16 (5) for fiscal year 2008, $10,500,000. 

17 TITLE VII—DRUG EDUCATION, 

18 PREVENTION, AND TREATMENT 

19 SEC. 701. EXPANSION OF SUBSTANCE ABUSE EDUCATION 

20 AND PREVENTION EFFORTS. 

21 (a) EXPANSION OF EFFORTS.—Section 515 of the 

22 Public Health Service Act (42 U.S.C. 290bb–21) is 

23 amended by adding at the end the following: 

24 ‘‘(e)(1) The Director of the Prevention Center may 

25 make grants to and enter into contracts and cooperative 
59

•S 1860 IS 

1 agreements with public and nonprofit private entities to 

2 enable such entities—

3 ‘‘(A) to carry out school-based programs con4 cerning the dangers of abuse of and addiction to il5 licit drugs, using methods that are effective and re6 search-based, including initiatives that give students 

7 the responsibility to create their own antidrug abuse 

8 education programs for their schools; and 

9 ‘‘(B) to carry out community-based abuse and 

10 addiction prevention programs relating to illicit 

11 drugs that are effective and research-based. 

12 ‘‘(2) Amounts made available under a grant, con13 tract, or cooperative agreement under paragraph (1) shall 

14 be used for planning, establishing, or administering pre15 vention programs relating to illicit drugs in accordance 

16 with paragraph (3). 

17 ‘‘(3)(A) Amounts provided under this subsection may 

18 be used—

19 ‘‘(i) to carry out school-based programs that 

20 are focused on those districts with high or increasing 

21 rates of drug abuse and addiction and targeted at 

22 populations which are most at-risk to start abuse of 

23 illicit drugs; 

24 ‘‘(ii) to carry out community-based prevention 

25 programs that are focused on those populations 
60

•S 1860 IS 

1 within the community that are most at-risk for 

2 abuse of and addiction to illicit drugs; 

3 ‘‘(iii) to assist local government entities to con4 duct appropriate prevention activities relating to il5 licit drugs; 

6 ‘‘(iv) to train and educate State and local law 

7 enforcement officials, prevention and education offi8 cials, members of community antidrug coalitions and 

9 parents on the signs of abuse of and addiction to il10 licit drugs, and the options for treatment and pre11 vention; 

12 ‘‘(v) for planning, administration, and edu13 cational activities related to the prevention of abuse 

14 of and addiction to illicit drugs; 

15 ‘‘(vi) for the monitoring and evaluation of pre16 vention activities relating to illicit drugs, and report17 ing and disseminating resulting information to the 

18 public; and 

19 ‘‘(vii) for targeted pilot programs with evalua20 tion components to encourage innovation and experi21 mentation with new methodologies. 

22 ‘‘(B) The Director of the Prevention Center shall give 

23 priority in making grants under this subsection to rural 

24 States, urban areas, and other areas that are experiencing 

25 a high rate or rapid increases in drug abuse and addiction. 
61

•S 1860 IS 

1 ‘‘(4)(A) Not less than $500,000 of the amount avail2 able in each fiscal year to carry out this subsection shall 

3 be made available to the Administrator, acting in consulta4 tion with other Federal agencies, to support and conduct 

5 periodic analyses and evaluations of effective prevention 

6 programs for abuse of and addiction to illicit drugs and 

7 the development of appropriate strategies for dissemi8 nating information about and implementing these pro9 grams. 

10 ‘‘(B) The Administrator shall submit to the commit11 tees of Congress referred to in subparagraph (C) an an12 nual report with the results of the analyses and evaluation 

13 conducted pursuant to subparagraph (A). 

14 ‘‘(C) The committees of Congress referred to in sub15 paragraph (B) are the following: 

16 ‘‘(i) The Committees on Health, Education, 

17 Labor, and Pensions, the Judiciary, and Appropria18 tions of the Senate. 

19 ‘‘(ii) The Committees on Energy and Com20 merce, the Judiciary, and Appropriations of the 

21 House of Representatives.’’. 

22 (b) AUTHORIZATION OF APPROPRIATIONS FOR EX23 PANSION OF ABUSE PREVENTION EFFORTS AND PRACTI24 TIONER REGISTRATION REQUIREMENTS.—There is au25 thorized to be appropriated to carry out section 515(e) of 
62

•S 1860 IS 

1 the Public Health Service Act (as added by subsection (a)) 

2 and section 303(g)(2) of the Controlled Substances Act 

3 (as added by section 18(a) of this Act), $100,000,000 for 

4 fiscal year 2005, and such sums as may be necessary for 

5 each succeeding fiscal year. 

6 (c) MINIMUM ALLOCATION.—Unless all eligible appli7 cations submitted by any State or unit of local government 

8 within such State for a grant under this section have been 

9 funded, such State, together with grantees within the 

10 State (other than Indian tribes), shall be allocated in each 

11 fiscal year under this section not less than 0.75 percent 

12 of the total amount appropriated in the fiscal year for 

13 grants pursuant to this section.

14 SEC. 702. FUNDING FOR RURAL STATES AND ECONOMI15 CALLY DEPRESSED COMMUNITIES. 

16 Subpart 1 of part B of title 5 of the Public Health 

17 Service Act (42 U.S.C. 290bb et seq.) is amended by in18 serting after section 509 the following: 

19 ‘‘SEC. 510. FUNDING FOR RURAL STATES AND ECONOMI20 CALLY DEPRESSED COMMUNITIES. 

21 ‘‘(a) IN GENERAL.—The Director of the Center for 

22 Substance Abuse Treatment (in this section referred to 

23 as the ‘Director’) may award grants, cooperative agree24 ments, or contracts to public and nonprofit private entities 

25 for the purpose of providing treatment facilities in rural
63

•S 1860 IS 

1 States and economically depressed communities that have 

2 high rates of drug addiction but lack the resources to pro3 vide adequate treatment. 

4 ‘‘(b) DURATION OF AWARD.—The Director shall 

5 award grants, cooperative agreements, and contracts 

6 under subsection (a) for a period not to exceed 5 years. 

7 Such awards shall be subject to annual approval by the 

8 Director and subject to the availability of appropriations 

9 for the fiscal year involved. This subsection may not be 

10 construed to establish a limitation on the number of 

11 awards that may be made to an entity. 

12 ‘‘(c) EQUITABLE ALLOCATION OF AWARDS.—In mak13 ing awards under subsection (a), the Director shall ensure 

14 that the awards are equitably allocated among the prin15 cipal geographic regions of the United States, subject to 

16 the availability of qualified applicants for the awards. 

17 ‘‘(d) APPLICATION.—Each entity desiring an award 

18 under subsection (a) shall submit to the Director an appli19 cation at such time, in such manner and containing such 

20 information as the Director determines necessary, includ21 ing a certification that—

22 ‘‘(1) the entity has the capacity to carry out a 

23 program described in subsection (a); 
64

•S 1860 IS 

1 ‘‘(2) the plans of the entity for such a program 

2 are consistent with the policies of such entity regard3 ing the treatment of substance abuse; and 

4 ‘‘(3) the entity, or any other entity through 

5 which the applicant will provide services, meets all 

6 applicable State licensure or certification require7 ments regarding the provision of the services in8 volved. 

9 ‘‘(e) REQUIREMENT OF MATCHING FUNDS.—

10 ‘‘(1) NON-FEDERAL SHARE.—Each entity re11 ceiving an award under this section shall make avail12 able (directly or through donations from public or 

13 private entities) non-Federal contributions toward 

14 the costs of activities funded by such an award in 

15 an amount that—

16 ‘‘(A) for the first fiscal year for which the 

17 applicant receives payments under the award, 

18 shall be not less than $1 for each $9 of Federal 

19 funds provided in the award; 

20 ‘‘(B) for any second such fiscal year, shall 

21 be not less than $1 for each $9 of Federal 

22 funds provided in the award; and 

23 ‘‘(C) for any subsequent fiscal year, shall 

24 be not less than $1 for each $3 of Federal 

25 funds provided in the award. 
65

•S 1860 IS 

1 ‘‘(2) DETERMINATION OF AMOUNT OF NON2 FEDERAL SHARE.—The non-Federal share of pay3 ments required under paragraph (1) may be in cash 

4 or in kind, fairly evaluated, including plant, equip5 ment, or services. Amounts provided by the Federal 

6 Government, or services assisted or subsidized to 

7 any significant extent by the Federal Government, 

8 may not be included in determining the amount of 

9 such non-Federal contributions. 

10 ‘‘(f) REPORTS TO DIRECTOR.—Not later than 1 year 

11 after receiving an award under subsection (a) and annu12 ally thereafter, each entity receiving an award under such 

13 subsection shall submit to the Director a report—

14 ‘‘(1) describing the use of the award and the 

15 costs of services provided under the award; 

16 ‘‘(2) specifying the number of individuals served 

17 by the award and the type and cost of services pro18 vided; and 

19 ‘‘(3) providing such other information as the 

20 Director determines to be appropriate. 

21 ‘‘(g) EVALUATIONS; DISSEMINATION OF FIND22 INGS.—The Director shall, directly or through contract, 

23 provide for the conduct of evaluations of programs carried 

24 out pursuant to subsection (a). The Director shall dissemi-
66

•S 1860 IS 

1 nate to the States the findings made as a result of the 

2 evaluations. 

3 ‘‘(h) MINIMUM ALLOCATION.—Unless all eligible ap4 plications submitted by any State or unit of local govern5 ment within such State for a grant under this section have 

6 been funded, such State, together with grantees within the 

7 State (other than Indian tribes), shall be allocated in each 

8 fiscal year under this section not less than 0.75 percent 

9 of the total amount appropriated in the fiscal year for 

10 grants under this section. 

11 ‘‘(i) DEFINITION OF RURAL STATE.—In this section, 

12 the term ‘rural State’ has the meaning given such term 

13 in section 1501(b) of the Omnibus Crime Control and Safe 

14 Streets Act of 1968 (42 U.S.C. 3796bb(B)). 

15 ‘‘(j) AUTHORIZATION OF APPROPRIATIONS.—There 

16 are authorized to be appropriated to carry out this section 

17 $50,000,000 for each of fiscal years 2005, 2006, and 

18 2007. 

19 ‘‘SEC. 511. FUNDING FOR RESIDENTIAL TREATMENT CEN20 TERS FOR WOMEN AND CHILDREN. 

21 ‘‘(a) IN GENERAL.—The Director of the Center for 

22 Substance Abuse Treatment (in this section referred to 

23 as the ‘Director’) may award grants, cooperative agree24 ments, or contracts to public and nonprofit private entities 

25 to establish treatment facilities that—
67

•S 1860 IS 

1 ‘‘(1) provide residential treatment for meth2 amphetamine-, heroin-, and other drug-addicted 

3 women with minor children; and 

4 ‘‘(2) offer specialized treatment for meth5 amphetamine-, heroin-, and other drug-addicted 

6 mothers and allow the minor children of those moth7 ers to reside with them in the facility or nearby 

8 while treatment is ongoing. 

9 ‘‘(b) DURATION OF AWARD.—The Director shall 

10 award grants, cooperative agreements, and contracts 

11 under subsection (a) for a period not to exceed 5 years. 

12 Such awards shall be subject to annual approval by the 

13 Director and subject to the availability of appropriations 

14 for the fiscal year involved. This subsection may not be 

15 construed to establish a limitation on the number of 

16 awards that may be made to an entity. 

17 ‘‘(c) EQUITABLE ALLOCATION OF AWARDS.—In mak18 ing awards under subsection (a), the Director shall ensure 

19 that the awards are equitably allocated among the prin20 cipal geographic regions of the United States, subject to 

21 the availability of qualified applicants for the awards. 

22 ‘‘(d) APPLICATION.—Each entity desiring an award 

23 under subsection (a) shall submit to the Director an appli24 cation at such time, in such manner and containing such
68

•S 1860 IS 

1 information as the Director determines necessary, includ2 ing a certification that—

3 ‘‘(1) the entity has the capacity to carry out a 

4 program described in subsection (a); 

5 ‘‘(2) the plans of the entity for such a program 

6 are consistent with the policies of such entity regard7 ing the treatment of substance abuse; and 

8 ‘‘(3) the entity, or any other entity through 

9 which the applicant will provide services, meets all 

10 applicable State licensure or certification require11 ments regarding the provision of the services in12 volved. 

13 ‘‘(e) PRIORITY.—In making grants under this sec14 tion, the Director shall give priority to areas experiencing 

15 a high rate or rapid increase in drug abuse and addiction. 

16 ‘‘(f) REQUIREMENT OF MATCHING FUNDS.—

17 ‘‘(1) NON-FEDERAL SHARE.—Each entity re18 ceiving an award under this section shall make avail19 able (directly or through donations from public or 

20 private entities) non-Federal contributions toward 

21 the costs of activities funded by such an award in 

22 an amount that—

23 ‘‘(A) for the first fiscal year for which the 

24 applicant receives payments under the award, 
69

•S 1860 IS 

1 shall be not less than $1 for each $9 of Federal 

2 funds provided in the award; 

3 ‘‘(B) for any second such fiscal year, shall 

4 be not less than $1 for each $9 of Federal 

5 funds provided in the award; and 

6 ‘‘(C) for any subsequent fiscal year, shall 

7 be not less than $1 for each $3 of Federal 

8 funds provided in the award. 

9 ‘‘(2) DETERMINATION OF AMOUNT OF NON10 FEDERAL SHARE.—The non-Federal share of pay11 ments required under paragraph (1) may be in cash 

12 or in kind, fairly evaluated, including plant, equip13 ment, or services. Amounts provided by the Federal 

14 Government, or services assisted or subsidized to 

15 any significant extent by the Federal Government, 

16 may not be included in determining the amount of 

17 such non-Federal contributions. 

18 ‘‘(g) REPORTS TO DIRECTOR.—Not later than 1 year 

19 after receiving an award under subsection (a) and annu20 ally thereafter, each entity receiving an award under such 

21 subsection shall submit to the Director a report—

22 ‘‘(1) describing the use of the award and the 

23 costs of services provided under the award; 
70

•S 1860 IS 

1 ‘‘(2) specifying the number of individuals served 

2 by the award and the type and cost of services pro3 vided; and 

4 ‘‘(3) providing such other information as the 

5 Director determines to be appropriate. 

6 ‘‘(h) EVALUATIONS; DISSEMINATION OF FIND7 INGS.—The Director shall, directly or through contract, 

8 provide for the conduct of evaluations of programs carried 

9 out pursuant to subsection (a). The Director shall dissemi10 nate to the States the findings made as a result of the 

11 evaluations. 

12 ‘‘(i) MINIMUM ALLOCATION.—Unless all eligible ap13 plications submitted by any State or units of local govern14 ment within such State for a grant under this section have 

15 been funded, such State, together with grantees within the 

16 State (other than Indian tribes), shall be allocated in each 

17 fiscal year under this section not less than 0.75 percent 

18 of the total amount appropriated in the fiscal year for 

19 grants under this section. 

20 ‘‘(j) AUTHORIZATION OF APPROPRIATIONS.—There 

21 are authorized to be appropriated to carry out this section 

22 $10,000,000 for each of fiscal years 2005, 2006, and 

23 2007.’’. 
71

•S 1860 IS 

1 SEC. 703. RESIDENTIAL TREATMENT PROGRAMS FOR JUVE2 NILES. 

3 Title V of the Public Health Service Act (42 U.S.C. 

4 290aa et seq.) is amended by adding at the end the fol5 lowing: 

6 ‘‘PART H—RESIDENTIAL TREATMENT PROGRAMS 

7 FOR JUVENILES 

8 ‘‘SEC. 591. RESIDENTIAL TREATMENT PROGRAMS FOR JU9 VENILES. 

10 ‘‘(a) IN GENERAL.—The Director of the Center for 

11 Substance Abuse Treatment (in this section referred to 

12 as the ‘Director’) may award grants, cooperative agree13 ments, or contracts to public and nonprofit private entities 

14 to provide treatment to juveniles for substance abuse 

15 through programs that—

16 ‘‘(1) are effective and science-based; and 

17 ‘‘(2) provide facilities in which the juveniles re18 side during the course of receiving such treatment. 

19 ‘‘(b) DURATION OF AWARD.—The Director shall 

20 award grants, cooperative agreements, and contracts 

21 under subsection (a) for a period not to exceed 5 years. 

22 Such awards shall be subject to annual approval by the 

23 Director and subject to the availability of appropriations 

24 for the fiscal year involved. This subsection may not be 

25 construed to establish a limitation on the number of 

26 awards that may be made to an entity. 
72

•S 1860 IS 

1 ‘‘(c) EQUITABLE ALLOCATION OF AWARDS.—In mak2 ing awards under subsection (a), the Director shall ensure 

3 that the awards are equitably allocated among the prin4 cipal geographic regions of the United States, as well as 

5 among Indian tribes, subject to the availability of qualified 

6 applicants for the awards. 

7 ‘‘(d) AVAILABILITY OF SERVICES FOR EACH PARTIC8 IPANT.— Each entity receiving an award under subsection 

9 (a) shall use the funds provided under such subsection to 

10 operate programs in which—

11 ‘‘(1) treatment services will be available either 

12 directly or through agreements with other public or 

13 nonprofit private entities; 

14 ‘‘(2) services will be made available to each per15 son admitted to the program; and 

16 ‘‘(3) the entity will, in consultation with the ju17 venile and, if appropriate the parent or guardian of 

18 the juvenile, prepare an individualized plan for the 

19 provision of treatment services including—

20 ‘‘(A) individual, group, and family coun21 seling, as appropriate, regarding substance 

22 abuse; and 

23 ‘‘(B) followup services to assist the juvenile 

24 or young adult in preventing a relapse into such 

25 abuse.
73

•S 1860 IS 

1 ‘‘(e) ELIGIBLE SUPPLEMENTAL SERVICES.—In addi2 tion to activities described in subsection (b), grants under 

3 subsection (a) may be used to provide the following serv4 ices: 

5 ‘‘(1) Referrals for necessary hospital services. 

6 ‘‘(2) Counseling on the human immuno7 deficiency virus and on acquired immune deficiency 

8 syndrome. 

9 ‘‘(3) Counseling on domestic violence and sexual 

10 abuse. 

11 ‘‘(4) Planning for and counseling to assist re12 entry into society, both before and after discharge, 

13 including referrals to any public or nonprofit private 

14 entities in the community involved that provide serv15 ices appropriate for the juvenile. 

16 ‘‘(f) APPLICATION.—Each entity desiring an award 

17 under subsection (a) shall submit to the Director an appli18 cation at such time, in such manner, and containing such 

19 information as the Director may require including a cer20 tification that—

21 ‘‘(1) the applicant has the capacity to carry out 

22 a program described in subsection (a); 

23 ‘‘(2) the plans of the applicant for the program 

24 are consistent with the policies of such agency re25 garding the treatment of substance abuse; 
74

•S 1860 IS 

1 ‘‘(3) the applicant, or any entity through which 

2 the applicant will provide services, meets all applica3 ble State licensure or certification requirements re4 garding the provision of the services involved; 

5 ‘‘(4) the applicant will provide outreach services 

6 in the community involved to identify juveniles who 

7 are engaging in substance abuse and to encourage 

8 the juveniles to undergo treatment for such abuse; 

9 ‘‘(5) the program will be operated at a location 

10 that is accessible to low-income juveniles; 

11 ‘‘(6) the applicant involved will provide for con12 tinuing education in treatment services for the indi13 viduals who will provide treatment in the program; 

14 and 

15 ‘‘(7) if a charge is imposed for the provision of 

16 services to or on behalf of a juvenile, such charge—

17 ‘‘(A) will be made according to a schedule 

18 of charges that is made available to the public; 

19 ‘‘(B) will be adjusted to reflect the eco20 nomic condition of the juvenile involved; and 

21 ‘‘(C) will not be imposed on any juvenile 

22 whose family has an income of less than 185 

23 percent of the poverty line, as established by 

24 the Director of the Office for Management and 

25 Budget and revised by the Secretary in accord-
75

•S 1860 IS 

1 ance with section 673(2) of the Omnibus Budg2 et Reconciliation Act of 1981 (42 U.S.C. 

3 9902(2)). 

4 ‘‘(g) PRIORITY.—In making grants under this sec5 tion, the Director shall give priority to areas experiencing 

6 a high rate or rapid increase in drug abuse and addiction. 

7 ‘‘(h) REQUIREMENT OF MATCHING FUNDS.—

8 ‘‘(1) NON-FEDERAL SHARE.—Each entity re9 ceiving an award under this section shall make avail10 able (directly or through donations from public or 

11 private entities) non-Federal contributions toward 

12 the costs of activities funded by such an award in 

13 an amount that—

14 ‘‘(A) for the first fiscal year for which the 

15 applicant receives payments under the award, 

16 shall be not less than $1 for each $9 of Federal 

17 funds provided in the award; 

18 ‘‘(B) for any second such fiscal year, shall 

19 be not less than $1 for each $9 of Federal 

20 funds provided in the award; and 

21 ‘‘(C) for any subsequent fiscal year, shall 

22 be not less than $1 for each $3 of Federal 

23 funds provided in the award. 

24 ‘‘(2) DETERMINATION OF AMOUNT OF NON25 FEDERAL SHARE.—The non-Federal share of pay-
76

•S 1860 IS 

1 ments required under paragraph (1) may be in cash 

2 or in kind, fairly evaluated, including plant, equip3 ment, or services. Amounts provided by the Federal 

4 Government, or services assisted or subsidized to 

5 any significant extent by the Federal Government, 

6 may not be included in determining the amount of 

7 such non-Federal contributions. 

8 ‘‘(i) REPORTS TO DIRECTOR.—Not later than 1 year 

9 after receiving an award under subsection (a) and annu10 ally thereafter, each entity receiving an award under such 

11 subsection shall submit to the Director a report—

12 ‘‘(1) describing the use of the award and the 

13 costs of services provided under the award; 

14 ‘‘(2) specifying the number of juveniles served 

15 by the award and the type and cost of services pro16 vided; and 

17 ‘‘(3) providing such other information as the 

18 Director determines to be appropriate. 

19 ‘‘(j) EVALUATIONS; DISSEMINATION OF FINDINGS.—

20 The Director shall, directly or through contract, provide 

21 for the conduct of evaluations of programs carried out 

22 pursuant to subsection (a). The Director shall disseminate 

23 to the States the findings made as a result of the evalua24 tions. 

25 ‘‘(k) REPORTS TO CONGRESS.—
77

•S 1860 IS 

1 ‘‘(1) INITIAL REPORT.—Not later than October 

2 1, 2005, the Director shall submit to the Committee 

3 on the Judiciary of the House of Representatives, 

4 and the Committee on the Judiciary of the Senate, 

5 a report describing programs carried out pursuant 

6 to this section. 

7 ‘‘(2) PERIODIC REPORTS.—Not less than bien8 nially after the date described in paragraph (1), the 

9 Director shall prepare a report describing programs 

10 carried out pursuant to this section during the pre11 ceding 2-year period, and shall submit the report to 

12 the Administrator for inclusion in the biennial report 

13 under section 501(k). 

14 ‘‘(3) SUMMARY.—Each report under this sub15 section shall include a summary of any evaluations 

16 conducted under subsection (j) during the period 

17 with respect to which the report is prepared. 

18 ‘‘(l) DEFINITIONS.—In this section: 

19 ‘‘(1) JUVENILE.—The term ‘juvenile’ means 

20 anyone 18 years of age or younger at the time of ad21 mission to a program operated pursuant to sub22 section (a). 

23 ‘‘(2) TREATMENT SERVICES.—The term ‘treat24 ment services’ means treatment for substance abuse,
78

•S 1860 IS 

1 including the counseling and services described in 

2 subsection (d)(3). 

3 ‘‘SEC. 592. OUTPATIENT TREATMENT PROGRAMS FOR JUVE4 NILES. 

5 ‘‘(a) GRANTS.—The Secretary, acting through the 

6 Director of the Center for Substance Abuse Treatment, 

7 shall make grants to eligible entities to establish projects 

8 for the outpatient treatment of substance abuse among ju9 veniles. 

10 ‘‘(b) PREVENTION.—Entities receiving grants under 

11 this section shall engage in activities to prevent substance 

12 abuse among juveniles. 

13 ‘‘(c) EVALUATION.—The Secretary shall evaluate 

14 projects carried out under subsection (a) and shall dis15 seminate to appropriate public and private entities infor16 mation on effective projects. 

17 ‘‘SEC. 593. AUTHORIZATION OF APPROPRIATIONS. 

18 ‘‘(a) IN GENERAL.—There are authorized to be ap19 propriated to carry out this part $100,000,000 for each 

20 of the fiscal years 2005 through 2007. 

21 ‘‘(b) MINIMUM ALLOCATION.—Unless all eligible ap22 plications submitted by any State or unit of local govern23 ment within such State for a grant under this part have 

24 been funded, such State, together with grantees within the 

25 State (other than Indian tribes), shall be allocated in each 
79

•S 1860 IS 

1 fiscal year under this section not less than 0.75 percent 

2 of the total amount appropriated in the fiscal year for 

3 grants pursuant to this section. 

4 ‘‘(c) TRANSFER.—In addition to the amounts author5 ized in subsection (a), there is authorized to be appro6 priated for the fiscal year from the special forfeiture fund 

7 of the Director of the Office of National Drug Control Pol8 icy such sums as may be necessary. 

9 ‘‘(d) RULE OF CONSTRUCTION.—The amounts au10 thorized to be appropriated in this section are in addition 

11 to any other amounts that are authorized to be appro12 priated and are available for drug treatment programs for 

13 juveniles.’’. 

14 SEC. 704. DRUG TREATMENT ALTERNATIVE TO PRISON 

15 PROGRAMS ADMINISTERED BY STATE OR 

16 LOCAL PROSECUTORS. 

17 (a) PROSECUTION DRUG TREATMENT ALTERNATIVE

18 TO PRISON PROGRAMS.—Title I of the Omnibus Crime 

19 Control and Safe Streets Act of 1968 (42 U.S.C. 3711 

20 et seq.) is amended by adding at the end the following 

21 new part: 
80

•S 1860 IS 

1 ‘‘PART CC—PROSECUTION DRUG TREATMENT 

2 ALTERNATIVE TO PRISON PROGRAMS 

3 ‘‘SEC. 2901. PILOT PROGRAM AUTHORIZED. 

4 ‘‘(a) IN GENERAL.—The Attorney General may make 

5 grants to State or local prosecutors for the purpose of de6 veloping, implementing, or expanding drug treatment al7 ternative to prison programs that comply with the require8 ments of this part. 

9 ‘‘(b) USE OF FUNDS.—A State or local prosecutor 

10 who receives a grant under this part shall use amounts 

11 provided under the grant to develop, implement, or expand 

12 the drug treatment alternative to prison programs for 

13 which the grant was made, which may include payment 

14 of the following expenses: 

15 ‘‘(1) Salaries, personnel costs, equipment costs, 

16 and other costs directly related to the operation of 

17 the program, including the enforcement unit. 

18 ‘‘(2) Payments to licensed substance abuse 

19 treatment providers for providing treatment to of20 fenders participating in the program for which the 

21 grant was made, including aftercare supervision, vo22 cational training, education, and job placement. 

23 ‘‘(3) Payments to public and nonprofit private 

24 entities for providing treatment to offenders partici25 pating in the program for which the grant was 

26 made. 
81

•S 1860 IS 

1 ‘‘(c) FEDERAL SHARE.—The Federal share of a 

2 grant under this part shall not exceed 75 percent of the 

3 cost of the program. 

4 ‘‘(d) SUPPLEMENT AND NOT SUPPLANT.—Grant 

5 amounts received under this part shall be used to supple6 ment, and not supplant, non-Federal funds that would 

7 otherwise be available for activities funded under this part. 

8 ‘‘SEC. 2902. PROGRAM REQUIREMENTS. 

9 ‘‘A drug treatment alternative to prison program with 

10 respect to which a grant is made under this part shall 

11 comply with the following requirements: 

12 ‘‘(1) A State or local prosecutor shall admin13 ister the program. 

14 ‘‘(2) An eligible offender may participate in the 

15 program only with the consent of the State or local 

16 prosecutor. 

17 ‘‘(3) Each eligible offender who participates in 

18 the program shall, as an alternative to incarceration, 

19 be sentenced to or placed with a long term, drug 

20 free residential substance abuse treatment provider 

21 that is licensed under State or local law. 

22 ‘‘(4) Each eligible offender who participates in 

23 the program shall serve a sentence of imprisonment 

24 with respect to the underlying crime if that offender 
82

•S 1860 IS 

1 does not successfully complete treatment with the 

2 residential substance abuse provider. 

3 ‘‘(5) Each residential substance abuse provider 

4 treating an offender under the program shall—

5 ‘‘(A) make periodic reports of the progress 

6 of treatment of that offender to the State or 

7 local prosecutor carrying out the program and 

8 to the appropriate court in which the defendant 

9 was convicted; and 

10 ‘‘(B) notify that prosecutor and that court 

11 if that offender absconds from the facility of 

12 the treatment provider or otherwise violates the 

13 terms and conditions of the program. 

14 ‘‘(6) The program shall have an enforcement 

15 unit comprised of law enforcement officers under the 

16 supervision of the State or local prosecutor carrying 

17 out the program, the duties of which shall include 

18 verifying an offender’s addresses and other contacts, 

19 and, if necessary, locating, apprehending, and ar20 resting an offender who has absconded from the fa21 cility of a residential substance abuse treatment pro22 vider or otherwise violated the terms and conditions 

23 of the program, and returning such offender to court 

24 for sentence on the underlying crime.
83

•S 1860 IS 

1 ‘‘SEC. 2903. APPLICATIONS. 

2 ‘‘(a) IN GENERAL.—To request a grant under this 

3 part, a State or local prosecutor shall submit an applica4 tion to the Attorney General in such form and containing 

5 such information as the Attorney General may reasonably 

6 require. 

7 ‘‘(b) CERTIFICATIONS.—Each such application shall 

8 contain the certification of the State or local prosecutor 

9 that the program for which the grant is requested shall 

10 meet each of the requirements of this part. 

11 ‘‘SEC. 2904. GEOGRAPHIC DISTRIBUTION. 

12 ‘‘The Attorney General shall ensure that, to the ex13 tent practicable, the distribution of grant awards is equi14 table and includes State or local prosecutors—

15 ‘‘(1) in each State; and 

16 ‘‘(2) in rural, suburban, and urban jurisdic17 tions. 

18 ‘‘SEC. 2905. REPORTS AND EVALUATIONS. 

19 ‘‘For each fiscal year, each recipient of a grant under 

20 this part during that fiscal year shall submit to the Attor21 ney General a report regarding the effectiveness of activi22 ties carried out using that grant. Each report shall include 

23 an evaluation in such form and containing such informa24 tion as the Attorney General may reasonably require. The 

25 Attorney General shall specify the dates on which such 

26 reports shall be submitted. 
84

•S 1860 IS 

1 ‘‘SEC. 2906. DEFINITIONS. 

2 ‘‘In this part: 

3 ‘‘(1) The term ‘State or local prosecutor’ means 

4 any district attorney, State attorney general, county 

5 attorney, or corporation counsel who has authority 

6 to prosecute criminal offenses under State or local 

7 law. 

8 ‘‘(2) The term ‘eligible offender’ means an indi9 vidual who—

10 ‘‘(A) has been convicted of, or pled guilty 

11 to, or admitted guilt with respect to a crime for 

12 which a sentence of imprisonment is required 

13 and has not completed such sentence; 

14 ‘‘(B) has never been convicted of, or pled 

15 guilty to, or admitted guilt with respect to, and 

16 is not presently charged with, a felony crime of 

17 violence, a major drug offense, including drug 

18 trafficking, or a crime that is considered a vio19 lent felony under State or local law; and 

20 ‘‘(C) has been found by a professional sub21 stance abuse screener to be in need of sub22 stance abuse treatment because that offender 

23 has a history of substance abuse that is a sig24 nificant contributing factor to that offender’s 

25 criminal conduct. 
85

•S 1860 IS 

1 ‘‘(3) The term ‘felony crime of violence’ has the 

2 meaning given such term in section 924(c)(3) of title 

3 18, United States Code. 

4 ‘‘(4) The term ‘major drug offense’ has the 

5 meaning given such term in section 36(a) of title 18, 

6 United States Code.’’. 

7 (b) AUTHORIZATION OF APPROPRIATIONS.—Section 

8 1001(a) of title I of the Omnibus Crime Control and Safe 

9 Streets Act of 1968 (42 U.S.C. 3793(a)) is amended by 

10 adding at the end the following new paragraph: 

11 ‘‘(24) There are authorized to be appropriated 

12 to carry out part CC $30,000,000 for each of fiscal 

13 years 2005 through 2007.’’. 

14 SEC. 705. FUNDING FOR RESIDENTIAL TREATMENT CEN15 TERS FOR WOMEN AND CHILDREN. 

16 (a) IN GENERAL.—The Director of the Center for 

17 Substance Abuse Treatment shall provide awards of 

18 grants, cooperative agreement, or contracts to public and 

19 nonprofit private entities for the purpose of providing 

20 treatment facilities that—

21 (1) provide residential treatment for meth22 amphetamine, heroin, and other drug addicted 

23 women with minor children; and 

24 (2) offer specialized treatment for methamphet25 amine-, heroin-, and other drug-addicted mothers 
86

•S 1860 IS 

1 and allow the minor children of those mothers to re2 side with them in the facility or nearby while treat3 ment is ongoing. 

4 (b) MINIMUM QUALIFICATIONS FOR RECEIPT OF

5 AWARD.—With respect to the principal agency of the 

6 State involved that administers programs relating to sub7 stance abuse, the Director may make an award under sub8 section (a) to an applicant only if the agency has certified 

9 to the Director that—

10 (1) the applicant has the capacity to carry out 

11 a program described in subsection (a); 

12 (2) the plans of the applicant for such a pro13 gram are consistent with the policies of such agency 

14 regarding the treatment of substance abuse; and 

15 (3) the applicant, or any entity through which 

16 the applicant will provide authorized services, meets 

17 all applicable State licensure or certification require18 ments regarding the provision of the services in19 volved. 

20 (c) REQUIREMENT OF MATCHING FUNDS.—

21 (1) IN GENERAL.—With respect to the costs of 

22 the program to be carried out by an applicant pursu23 ant to subsection (a), a funding agreement for an 

24 award under such subsection is that the applicant 

25 will make available (directly or through donations 
87

•S 1860 IS 

1 from public or private entities) non-Federal con2 tributions toward such costs in an amount that—

3 (A) for the first fiscal year for which the 

4 applicant receives payments under an award 

5 under such subsection, is not less than $1 for 

6 each $9 of Federal funds provided in the 

7 award; 

8 (B) for any second such fiscal year, is not 

9 less than $1 for each $9 of Federal funds pro10 vided in the award; and 

11 (C) for any subsequent such fiscal year, is 

12 not less than $1 for each $3 of Federal funds 

13 provided in the award. 

14 (2) DETERMINATION OF AMOUNT CONTRIB15 UTED.—Non-Federal contributions required in para16 graph (1) may be in cash or in kind, fairly evalu17 ated, including plant, equipment, or services. 

18 Amounts provided by the Federal Government, or 

19 services assisted or subsidized to any significant ex20 tent by the Federal Government, may not be in21 cluded in determining the amount of such non-Fed22 eral contributions. 

23 (d) REPORTS TO DIRECTOR.—A funding agreement 

24 for an award under subsection (a) is that the applicant 

25 involved will submit to the Director a report—
88

•S 1860 IS 

1 (1) describing the utilization and costs of serv2 ices provided under the award; 

3 (2) specifying the number of individuals served 

4 and the type and costs of services provided; and 

5 (3) providing such other information as the Di6 rector determines to be appropriate. 

7 (e) REQUIREMENT OF APPLICATION.—The Director 

8 may make an award under subsection (a) only if an appli9 cation for the award is submitted to the Director con10 taining such agreements, and the application is in such 

11 form, is made in such manner, and contains such other 

12 agreements and such assurances and information as the 

13 Director determines to be necessary to carry out this sec14 tion. 

15 (f) PRIORITY.—In making grants under this section, 

16 the Director shall give priority to areas experiencing a 

17 high rate or rapid increase in drug abuse and addiction. 

18 (g) EQUITABLE ALLOCATION OF AWARDS.—In mak19 ing awards under subsection (a), the Director shall ensure 

20 that the awards are equitably allocated among the prin21 cipal geographic regions of the United States, subject to 

22 the availability of qualified applicants for the awards. 

23 (h) DURATION OF AWARD.—The period during which 

24 payments are made to an entity from an award under sub25 section (a) may not exceed 5 years. The provision of such 
89

•S 1860 IS 

1 payments shall be subject to annual approval by the Direc2 tor of the payments and subject to the availability of ap3 propriations for the fiscal year involved to make the pay4 ments. This subsection may not be construed to establish 

5 a limitation on the number of awards under such sub6 section that may be made to an entity. 

7 (i) EVALUATIONS; DISSEMINATION OF FINDINGS.—

8 The Director shall, directly or through contract, provide 

9 for the conduct of evaluations of programs carried out 

10 pursuant to subsection (a). The Director shall disseminate 

11 to the States the findings made as a result of the evalua12 tions. 

13 (j) MINIMUM ALLOCATION.—Unless all eligible appli14 cations submitted by any State or unit of local government 

15 within such State for a grant under this section have been 

16 funded, such State, together with grantees within the 

17 State (other than Indian tribes), shall be allocated in each 

18 fiscal year under this section not less than 0.75 percent 

19 of the total amount appropriated in the fiscal year for 

20 grants pursuant to this section. 

21 (k) AUTHORIZATION OF APPROPRIATIONS.—There 

22 are authorized to be appropriated to carry out this section 

23 such sums as may be necessary for each of the fiscal years 

24 2005, 2006, and 2007. 
90

•S 1860 IS 

1 TITLE VIII—ANABOLIC STEROID 

2 CONTROL ACT OF 2003

3 SEC. 801. SHORT TITLE. 

4 This title may be cited as the ‘‘Anabolic Steroid Con5 trol Act of 2003’’. 

6 SEC. 802. AMENDMENTS TO THE CONTROLLED SUB7 STANCES ACT. 

8 (a) DEFINITIONS.—Section 102 of the Controlled 

9 Substances Act (21 U.S.C. 802) is amended—

10 (1) in paragraph (41)—

11 (A) by realigning the margin so as to align 

12 with paragraph (40); 

13 (B) by striking subparagraph (A) and in14 serting the following: 

15 ‘‘(A) The term ‘anabolic steroid’ means any drug or 

16 hormonal substance, chemically and pharmacologically re17 lated to testosterone (other than estrogens, progestins, 

18 corticosteroids, and dehydroepiandrosterone), and in19 cludes—

20 ‘‘(i) androstanediol—

21 ‘‘(I) 3β,17β-dihydroxy-5α-androstane; and 

22 ‘‘(II) 3α,17β-dihydroxy-5α-androstane; 

23 ‘‘(ii) androstanedione (5α-androstan-3,17-

24 dione); 

25 ‘‘(iii) androstenediol—
91

•S 1860 IS 

1 ‘‘(I) 1-androstenediol (3β,17β-dihydroxy2 5α-androst-1-ene); 

3 ‘‘(II) 1-androstenediol (3α,17β-dihydroxy4 5α-androst-1-ene); 

5 ‘‘(III) 4-androstenediol (3β,17β-dihydroxy6 androst-4-ene); and 

7 ‘‘(IV) 5-androstenediol (3b,17β-dihydroxy8 androst-5-ene); 

9 ‘‘(iv) androstenedione—

10 ‘‘(I) 1-androstenedione ([5α]-androst-1-en11 3,17-dione); 

12 ‘‘(II) 4-androstenedione (androst-4-en13 3,17-dione); and 

14 ‘‘(III) 5-androstenedione (androst-5-en15 3,17-dione); 

16 ‘‘(v) bolasterone (7α,17α-dimethyl-17β17 hydroxyandrost-4-en-3-one); 

18 ‘‘(vi) boldenone (17β-hydroxyandrost-1,4,-diene19 3-one); 

20 ‘‘(vii) calusterone (7β,17α-dimethyl-17β21 hydroxyandrost-4-en-3-one); 

22 ‘‘(viii) clostebol (4-chloro-17β-hydroxyandrost-4-

23 en-3-one); 

24 ‘‘(ix) dehydrochlormethyltestosterone (4-chloro25 17β-hydroxy-17α-methyl-androst-1,4-dien-3-one); 
92

•S 1860 IS 

1 ‘‘(x) 4-dihydrotestosterone (17β-hydroxy2 androstan-3-one); 

3 ‘‘(xi) drostanolone (17β-hydroxy-2α-methyl-5α4 androstan-3-one); 

5 ‘‘(xii) ethylestrenol (17α-ethyl-17β-hydroxyestr6 4-ene); 

7 ‘‘(xiii) fluoxymesterone (9-fluoro-17α-methyl8 11β,17β-dihydroxyandrost-4-en-3-one); 

9 ‘‘(xiv) formebolone (2-formyl-17α-methyl10 11α,17β-dihydroxyandrost-1,4-dien-3-one); 

11 ‘‘(xv) furazabol (17α-methyl-17β12 hydroxyandrostano[2,3-c]-furazan); 

13 ‘‘(xvi) 18α-homo-17β-hydroxyestr-4-en-3-one 

14 (13β-ethyl-17β-hydroxygon-4-en-3-one); 

15 ‘‘(xvii) 4-hydroxytestosterone (4,17β-dihydroxy16 androst-4-en-3-one); 

17 ‘‘(xviii) 4-hydroxy-19-nortestosterone (4,17β18 dihydroxy-estr-4-en-3-one); 

19 ‘‘(xix) mestanolone (17α-methyl-17β-hydroxy20 5α-androstan-3-one); 

21 ‘‘(xx) mesterolone (1α-methyl-17β-hydroxy22 [5α]-androstan-3-one); 

23 ‘‘(xxi) methandienone (17α-methyl-17β24 hydroxyandrost-1,4-dien-3-one);
93

•S 1860 IS 

1 ‘‘(xxii) methandriol (17α-methyl-3β,17β2 dihydroxyandrost-5-ene); 

3 ‘‘(xxiii) methenolone (1-methyl-17β-hydroxy-5α4 androst-1-en-3-one); 

5 ‘‘(xxiv) methyltestosterone (17α-methyl-17β6 hydroxyandrost-4-en-3-one); 

7 ‘‘(xxv) mibolerone (7α,17α-dimethyl-17β8 hydroxyestr-4-en-3-one); 

9 ‘‘(xxvi) nandrolone (17β-hydroxyestr-4-en-3-

10 one); 

11 ‘‘(xxvii) norandrostenediol—

12 ‘‘(I) 19-nor-4-androstenediol (3β, 17β13 dihydroxyestr-4-ene); 

14 ‘‘(II) 19-nor-4-androstenediol (3α, 17β15 dihydroxyestr-4-ene); 

16 ‘‘(III) 19-nor-5-androstenediol (3β, 17β17 dihydroxyestr-5-ene); and 

18 ‘‘(IV) 19-nor-5-androstenediol (3α, 17β19 dihydroxyestr-5-ene); 

20 ‘‘(xxviii) norandrostenedione—

21 ‘‘(I) 19-nor-4-androstenedione (estr-4-en22 3,17-dione); and 

23 ‘‘(II) 19-nor-5-androstenedione (estr-5-en24 3,17-dione); 
94

•S 1860 IS 

1 ‘‘(xxix) norbolethone (18α-homo-17β2 hydroxypregna-4-en-3-one); 

3 ‘‘(xxx) norclostebol (4-chloro-17β-hydroxyestr-4-

4 en-3-one); 

5 ‘‘(xxxi) norethandrolone (17α-ethyl-17β6 hydroxyestr-4-en-3-one); 

7 ‘‘(xxxii) oxandrolone (17α-methyl-17β-hydroxy8 2-oxa-[5α]-androstan-3-one); 

9 ‘‘(xxxiii) oxymesterone (17α-methyl-4,17β10 dihydroxyandrost-4-en-3-one); 

11 ‘‘(xxxiv) oxymetholone (17α-methyl-2-

12 hydroxymethylene-17β-hydroxy-[5α]-androstan-3-

13 one); 

14 ‘‘(xxxv) stanozolol (17α-methyl-17β-hydroxy15 [5α]-androst-2-eno[3,2-c]-pyrazole); 

16 ‘‘(xxxvi) stenbolone (17β-hydroxy-2-methyl17 [5α]-androst-1-en-3-one); 

18 ‘‘(xxxvii) testolactone (13-hydroxy-3-oxo-13,17-

19 secoandrosta-1,4-dien-17-oic acid lactone); 

20 ‘‘(xxxviii) 1-testosterone (17β-Hydroxy-5α21 androst-1-en-3-one); 

22 ‘‘(xxxix) testosterone (17β-hydroxyandrost-4-en23 3-one); 

24 ‘‘(xl) tetrahydrogestrinone (13β,17α-diethyl25 17β-hydroxygon-4,9,11-trien-3-one); 
95

•S 1860 IS 

1 ‘‘(xli) trenbolone (17β-hydroxyestr-4,9,11-trien2 3-one); and 

3 ‘‘(xlii) any salt, ester, or ether of a drug or sub4 stance described in this paragraph; and 

5 (C) by adding at the end the following: 

6 ‘‘(C) Notwithstanding subparagraph (A), the Attor7 ney General may not schedule Androstenedione as a con8 trolled substance in accordance with this Act until the At9 torney General receives a finding from the Commissioner 

10 of Food and Drugs relating to whether Androstenedione 

11 is lawfully marketed under the Federal Food, Drug, and 

12 Cosmetic Act (21 U.S.C. 321 et seq.).’’; and 

13 (2) in paragraph (44), by inserting ‘‘anabolic 

14 steroids,’’ after ‘‘marihuana,’’. 

15 (b) AUTHORITY AND CRITERIA FOR CLASSIFICA16 TION.—Section 201(g) of the Controlled Substances Act 

17 (21 U.S.C. 811(g)) is amended—

18 (1) in paragraph (1), by striking ‘‘substance 

19 from a schedule if such substance’’ and inserting 

20 ‘‘drug which contains a controlled substance from 

21 the application of titles II and III of the Comprehen22 sive Drug Abuse Prevention and Control Act (21 

23 U.S.C. 802 et seq.) if such drug’’; and 

24 (2) in paragraph (3), by adding at the end the 

25 following: 
96

•S 1860 IS 

1 ‘‘(C) Upon the recommendation of the Sec2 retary of Health and Human Services, a compound, 

3 mixture, or preparation which contains any anabolic 

4 steroid, which is intended for administration to a 

5 human being or an animal, and which, because of its 

6 concentration, preparation, formulation or delivery 

7 system, does not present any significant potential for 

8 abuse.’’. 

9 (c) ANABOLIC STEROIDS CONTROL ACT.—Section 

10 1903 of the Anabolic Steroids Control Act of 1990 (Public 

11 Law 101–647) is amended—

12 (1) by striking subsection (a); and 

13 (2) by redesignating subsections (b) and (c) as 

14 subsections (a) and (b), respectively. 

15 SEC. 803. SENTENCING COMMISSION GUIDELINES. 

16 The United States Sentencing Commission shall—

17 (1) review the Federal sentencing guidelines 

18 with respect to offenses involving anabolic steroids; 

19 (2) consider amending the Federal sentencing 

20 guidelines to provide for increased penalties with re21 spect to offenses involving anabolic steroids in a 

22 manner that reflects the seriousness of such offenses 

23 and the need to deter anabolic steroid use; and 

24 (3) take such other action that the Commission 

25 considers necessary to carry out this section. 
97

•S 1860 IS 

1 SEC. 804. PREVENTION AND EDUCATION PROGRAMS. 

2 (a) IN GENERAL.—The Secretary of Health and 

3 Human Services (referred to in this Act as the ‘‘Sec4 retary’’) shall award grants to public and nonprofit private 

5 entities to enable such entities to carry out science-based 

6 education programs in elementary and secondary schools 

7 to highlight the harmful effects of anabolic steroids. 

8 (b) ELIGIBILITY.—

9 (1) APPLICATION.—To be eligible for grants 

10 under subsection (a), an entity shall prepare and 

11 submit to the Secretary an application at such time, 

12 in such manner, and containing such information as 

13 the Secretary may require. 

14 (2) PREFERENCE.—In awarding grants under 

15 subsection (a), the Secretary shall give preference to 

16 applicants that intend to use grant funds to carry 

17 out programs based on—

18 (A) the Athletes Training and Learning to 

19 Avoid Steroids program; 

20 (B) the Athletes Targeting Healthy Exer21 cise and Nutrition Alternatives program; and 

22 (C) other programs determined to be effec23 tive by the National Institute on Drug Abuse. 

24 (c) USE OF FUNDS.—Amounts received under a 

25 grant under subsection (a) shall be used primarily for edu26 cation programs that will directly communicate with
98

•S 1860 IS 

1 teachers, principals, coaches, as well as elementary and 

2 secondary school children concerning the harmful effects 

3 of anabolic steroids. 

4 (d) AUTHORIZATION OF APPROPRIATIONS.—There is 

5 authorized to be appropriated to carry out this section, 

6 $15,000,000 for each of fiscal years 2004 through 2009. 

7 SEC. 805. NATIONAL SURVEY ON DRUG USE AND HEALTH. 

8 (a) IN GENERAL.—The Secretary of Health and 

9 Human Services shall ensure that the National Survey on 

10 Drug Use and Health includes questions concerning the 

11 use of anabolic steroids. 

12 (b) AUTHORIZATION OF APPROPRIATIONS.—There is 

13 authorized to be appropriated to carry out this section, 

14 $1,000,000 for each of fiscal years 2004 through 2009. 

15 TITLE IX—NATIONAL GUARD 

16 COUNTER-DRUG SCHOOLS 

17 SEC. 901. NATIONAL GUARD COUNTER-DRUG SCHOOLS. 

18 (a) AUTHORITY TO OPERATE.—Under such regula19 tions as the Secretary of Defense may prescribe, the Chief 

20 of the National Guard Bureau may establish and operate, 

21 or provide financial assistance to the States to establish 

22 and operate, not more than five schools (to be known gen23 erally as ‘‘National Guard counter-drug schools’’). 

24 (b) PURPOSE.—The purpose of the National Guard 

25 counter-drug schools shall be the provision by the National 
99

•S 1860 IS 

1 Guard of training in drug interdiction and counter-drug 

2 activities and drug demand reduction activities to per3 sonnel of the following: 

4 (1) Federal agencies. 

5 (2) State and local law enforcement agencies. 

6 (3) Community-based organizations engaged in 

7 such activities. 

8 (4) Other non-Federal governmental and pri9 vate entities and organizations engaged in such ac10 tivities. 

11 (c) COUNTER-DRUG SCHOOLS SPECIFIED.—The Na12 tional Guard counter-drug schools operated under the au13 thority in subsection (a) are as follows: 

14 (1) The National Interagency Civil-Military In15 stitute (NICI), San Luis Obispo, California. 

16 (2) The Multi-Jurisdictional Counterdrug Task 

17 Force Training (MCTFT), St. Petersburg, Florida. 

18 (3) The Midwest Counterdrug Training Center 

19 (MCTC), Johnston, Iowa. 

20 (4) The Regional Counterdrug Training Acad21 emy (RCTA), Meridian, Mississippi. 

22 (5) The Northeast Regional Counterdrug Train23 ing Center (NCTC), Fort Indiantown Gap, Pennsyl24 vania. 
100

•S 1860 IS 

1 (d) USE OF NATIONAL GUARD PERSONNEL.—(1) To 

2 the extent provided for in the State drug interdiction and 

3 counter-drug activities plan of a State in which a National 

4 Guard counter-drug school is located, personnel of the Na5 tional Guard of that State who are ordered to perform 

6 full-time National Guard duty authorized under section 

7 112(b) of that title 32, United States Code, may provide 

8 training referred to in subsection (b) at that school. 

9 (2) In this subsection, the term ‘‘State drug interdic10 tion and counter-drug activities plan’’, in the case of a 

11 State, means the current plan submitted by the Governor 

12 of the State to the Secretary of Defense under section 112 

13 of title 32, United States Code. 

14 (e) TREATMENT UNDER AUTHORITY TO PROVIDE

15 COUNTER-DRUG SUPPORT.—The provisions of section 

16 1004 of the National Defense Authorization Act for Fiscal 

17 Year 1991 (Public Law 101–510; 10 U.S.C. 374 note) 

18 shall apply to any activities of a National Guard counter19 drug school under this section that are for an agency re20 ferred to in subsection (a) of such section 1004 and for 

21 a purpose set forth in subsection (b) of such section 1004. 

22 (f) ANNUAL REPORTS ON ACTIVITIES.—(1) Not later 

23 than February 1 each year, the Secretary of Defense shall 

24 submit to Congress a report on the activities of the Na-
101

•S 1860 IS 

1 tional Guard counter-drug schools during the preceding 

2 year. 

3 (2) Each report under paragraph (1) shall set forth 

4 the following: 

5 (A) The amount made available for each Na6 tional Guard counter-drug school during the fiscal 

7 year ending in the year preceding the year in which 

8 such report is submitted. 

9 (B) A description of the activities of each Na10 tional Guard counter-drug school during the year 

11 preceding the year in which such report is sub12 mitted. 

13 (g) BUDGET MATTERS.—The budget of the President 

14 that is submitted to Congress under section 1105 of title 

15 31, United States Code, for any fiscal year after fiscal 

16 year 2004 shall set forth as a separate budget item the 

17 amount requested for such fiscal year for the National 

18 Guard counter-drug schools. 

19 (h) AUTHORIZATION OF APPROPRIATIONS.—(1) 

20 There is hereby authorized to be appropriated for the De21 partment of Defense for the National Guard for each of 

22 fiscal years 2004 through 2008, $30,000,000 for purposes 

23 of the National Guard counter-drug schools in such fiscal 

24 year. 
102

•S 1860 IS 

1 (2) The amount authorized to be appropriated by 

2 paragraph (1) for a fiscal year is in addition to any other 

3 amount authorized to be appropriated for the Department 

4 of Defense for the National Guard for such fiscal year. 

5 TITLE X—MISCELLANEOUS 

6 PROVISIONS 

7 SEC. 1001. REPEALS. 

8 Sections 709, 710, and 711 are repealed. 

9 SEC. 1002. AMENDMENT TO THE HIGHER EDUCATION ACT 

10 OF 1965. 

11 Section 484(r)(1) of the Higher Education Act of 

12 1965 (20 U.S.C. 1091(r)(1)) is amended by striking ev13 erything preceding the table and inserting the following: 

14 ‘‘(1) IN GENERAL.—A student who is convicted 

15 of any offense under any Federal or State law in16 volving the possession or the sale of a controlled sub17 stance for conduct that occurred during a period of 

18 enrollment for which the student was receiving any 

19 grant, loan, or work assistance under this title shall 

20 not be eligible to receive such grant, loan, or work 

21 assistance from the date of conviction for the period 

22 of time specified in the following table:’’.
103

•S 1860 IS 

1 SEC. 1003. CONTROLLED SUBSTANCES ACT AMENDMENTS. 

2 (a) TECHNICAL CHANGE.—Section 303(g)(2)(B) of 

3 the Controlled Substances Act (21 U.S.C. 823(g)(2)(B)) 

4 is amended by striking clause (iv). 

5 (b) EFFECTIVE DATA PROVISION.—Section 

6 303(g)(2)(J)(ii) of the Controlled Substances Act (21 

7 U.S.C. 823(g)(2)(J)(ii)) is amended by striking ‘‘of the 

8 enactment of the Drug Addiction Treatment Act of 2000’’ 

9 and inserting in its place ‘‘the drugs or combinations of 

10 drugs have, under the Federal Food, Drug and Cosmetics 

11 Act or section 351 of the Public Health Services Act, been 

12 approved for use in maintenance or detoxification treat13 ment as required under paragraph (C)(i)’’. 

14 SEC. 1004. EXPORTATION OF NARCOTIC AND NONNAR15 COTIC DRUGS. 

16 Section 1003 of the Controlled Substance Import and 

17 Export Act (21 U.S.C. 953) is amended—

18 (1) in subsection (a), by striking paragraph (4) 

19 and inserting the following: 

20 ‘‘(4) substantial evidence is furnished to the At21 torney General by the exporter that the narcotic 

22 drug is to be applied exclusively to medical, sci23 entific, or other legitimate uses; and’’; and 

24 (2) in subsection (c), by striking paragraph (3) 

25 and inserting the following: 
104

•S 1860 IS 

1 ‘‘(3) substantial evidence is furnished to the At2 torney General by the exporter that the controlled 

3 substance is to be applied exclusively to medical, sci4 entific, or other legitimate uses; and’’. 

5 SEC. 1005. STUDY OF WORK PLACE ENVIRONMENT AT 

6 ONDCP. 

7 Not later than 90 days after the date of enactment 

8 of this Act, the Comptroller General of the United States 

9 shall submit a report to Congress on the workplace envi10 ronment at the Office of National Drug Control Policy, 

11 including an assessment of the turnover rate of employees 

12 and any sexual harassment or hostile work environment 

13 claims. 

14 SEC. 1006. REQUIREMENT FOR LATIN AMERICAN HEROIN 

15 STRATEGY. 

16 (a) IN GENERAL.—Not later than 90 days after the 

17 date of enactment of this Act, the Director of National 

18 Drug Control Policy shall submit to Congress a com19 prehensive strategy that addresses the increased threat 

20 from Latin American heroin, and in particular Colombian 

21 heroin. 

22 (b) CONTENTS.—The strategy shall include a plan 

23 for—
105

•S 1860 IS 

1 (1) opium eradication efforts to eliminate the 

2 problem at the source to prevent it from reoccurring 

3 before the heroin enters the stream of commerce; 

4 (2) interdiction and precursor chemical con5 trols; 

6 (3) demand reduction and treatment; 

7 (4) provisions that ensure the maintenance at 

8 current levels of efforts to eradicate coca in Colom9 bia; and 

10 (5) assessment of the level of additional funding 

11 and resources necessary to simultaneously address 

12 the threat from Latin American heroin and the 

13 threat from Colombian coca.

Æ